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1. Introduction 
1.1 Epigenetics and DNA methylation 
Epigenetics is the study of stable alterations in the gene expression (Jaenisch and Bird, 2003). 
It presents a new dimension to the genetic information encoded by four bases in the DNA. 
The usage extent of the genetic information is regulated by the alterations. These alterations 
are much more subject to environmental influences than the DNA sequence. Therefore, they 
play a central role in ageing, mental health and infertility (Qiu, 2006). The abnormalities in 
epigenetic mechanisms are associated with the disease formations. With the Human Genome 
Project completed, epigenetics holds a great prospect to extend this genetic information to 
develop novel diagnostic tools and drugs for diseases. 
Epigenetic machinery constrains the gene regulation by either modifying the gene directly 
(DNA methylation) or by modifying the histone proteins that are closely associated with the 
genes (Jones and Taylor, 1980; Kouzarides, 2007). These two mechanisms are described 
below: 
 DNA methylation: DNA methylation is found in genomes of prokaryotes and 
eukaryotes. In prokaryotes, it functions as a part of the host restriction-modification 
system (Murray, 2002). The methylation takes place on both cytosine and adenine 
bases. In multicellular eukaryotes, it occurs mostly on cytosine bases. In mammalians 
it happens mostly at CpG dinucleotides and its presence is associated with the 
repressed chromatin state and inhibition of gene expression (Weber and Schubeler, 
2007; Bird, 1986; Razin and Riggs, 1980; Jones et al., 1998). 
There are two proposed biological mechanisms for DNA methylation-mediated gene 
repression: Methyl modification can either prevent the binding of some transcription 
factors or it can affect the chromatin state indirectly by employing methyl CpG 
binding proteins (Klose and Bird, 2006). 
DNA methylation reaction is catalyzed by DNA methyltransferases (Jeltsch, 2002; 
Bestor, 2000). DNA MTases use the activated methyl group of the cofactor  
S-adenosyl-L-methionine (AdoMet) to catalyze the nucleophilic attack of either 
adenine or cytosine residues within specific double-stranded DNA sequences. DNA 
MTases can be categorized into three classes according to their target base and 
methylation position (Scheme 1). They modify the exocyclic nitrogen at the 6 position 
of adenine (adenine-N6-DNA-MTases), the exocyclic nitrogen at the 4 position of 
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cytosine (cytosine-N4-DNA-MTases) or carbon at the 5 position of cytosine  
(cytosine-C5-DNA-MTases).  
 
 
 
Scheme 1: Reactions catalyzed by DNA MTases. DNA MTases catalyze the nucleophilic 
attack of the exocyclic amino group of adenine, the exocyclic amino group of cytosine or C5 
of the cyclic ring of cytosine within their recognition sequences (thick black lines). DNA 
MTases use AdoMet (1) as the methyl source for the reaction. 
 
 Histone protein modifications: Histones are DNA packaging proteins and their role 
is critical for genome wide information storage and retrieval. There are three main 
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covalent histone modifications that regulate this information flow process; acetylation, 
phosphorylation and methylation (Rea et al., 2000; Lachner et al., 2001). These 
modifications contribute to mechanisms that can change the chromatin structure to 
transcriptional “on-off” states (see Jenuwein and Allis, 2001 for a comprehensive 
review).  
 
1.2 DNA methylation and disease susceptibility 
DNA methylation is an important regulator of gene transcription and the abnormalities in its 
function are associated with disease formation (Li et al., 1992). Studies show that aberrant 
DNA methylation is a significant reason for cancer formation (Das and Singal, 2004;  
Laird, 2005; Jones and Baylin, 2002). Furthermore, the differences in normal and tumor cell 
methylation patterns emerge as cancer markers and they can be used to detect the presence of 
tumor cells in biopsy specimen or to identify tumor related DNA in blood samples. Abnormal 
behavior of DNA methylation and related diseases can be classified under three groups: 
 Hypermethylation (silencing) of CpG islands of tumor suppressor genes: CpG 
islands are regions of DNA, which are often located near transcription start sites of 
genes. These genes contain a high frequency of CpG dinucleotides. In most 
mammalian genes, these regions are normally maintained without DNA methylation, 
however in cancer cells, CpG islands of various tumor-suppressor genes are frequently 
methylated. Methylation results in repression of transcription (silencing) and loss of 
functions in these genes may contribute to tumor formation (Baylin and Ohm, 2006; 
Jones and Laird, 1999; Baylin et al., 1998).  
 Global genomic hypomethylation: The regulatory role of DNA methylation contains 
vital functions in human such as silencing of parasitic sequences, X-chromosome 
inactivation, chromatin organization, tissue-specific methylation and genetic 
imprinting (Esteller and Herman, 2002; Okano et al., 1999). Therefore, global loss of 
methylation can cause genomic instability and consequently tumor formation. 
 Genetic defects in methyl-chromatin related genes: The appearance of genetic 
defects in chromatin-related genes forms disorders such as Rett syndrome  
(Amir et al., 1999). Many proteins related with CpG islands are under investigation to 
understand the comprehensive mechanisms about regulation and diseases. 
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1.3 DNA methylation detection methods 
The role of DNA methylation alterations in cancer formation is well established. The 
alterations mentioned in 1.2 provide a basis for target identification. These targets can be used 
for detection of tumor cells in tissue biopsies, blood or body fluids. Detection of DNA 
methylation alterations at a molecular level offers several advantages over imaging and 
traditional pathology because either the alteration precedes obvious cancer or the abnormal 
cells represent a tiny fraction of cell population and in both cases early treatment would 
increase a patient’s chance of survival. DNA is an ideal substrate for molecular detection 
because it is robust against harsh conditions that clinical specimens undergo, and can be 
amplified by PCR-based techniques, which enable the analysis of low amounts (Cairns, 2007).  
Generally examination of DNA methylation is performed in two steps. In a pre-analytical 
step, DNA is purified from biopsies and blood samples. This step is followed by bisulfite 
conversion and clean-up. In the analytical step, converted DNA is generally analyzed by  
high-throughput methods such as sequencing, PCR and microarrays (Scheme 2). Resulting 
data reveal the methylation patterns of samples.  
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Scheme 2: Overview of conventional DNA methylation detection steps. The pre-analytical 
step consists of isolation and conversion of sample DNA. Converted DNA is identified in the 
analytical step. Sequencing, real-time PCR and gel-based analysis are common analytical 
methods to characterize the converted DNA. 
 
The gold standard for DNA methylation analysis is bisulfite sequencing (see Ushijima, 2005 
for a comprehensive review on detection methods; Frommer et al., 1992; Clark et al., 1994; 
Herman et al., 1996; Esteller et al., 1999). The bisulfite treatment converts unmethylated 
cytosines to uracils while methylated cytosines remain unchanged (Scheme 3). Amplification 
of the uracils result in thymines to differentiate unmethylated DNA vs. methylated DNA. The 
limitations of bisulfite sequencing method are low sequence specificity associated with 
cytosine conversion, detrimental effects to DNA structure and total analysis time. 
 
Pre-analytical step
•DNA purification from 
biopsies and blood samples
•DNA conversion by bisulfite 
treatment
Converted DNA
Analytical step
•Sequencing
•Real time PCR
•Gel-based analysis
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Scheme 3: The gold standard in DNA methylation detection is bisulfite treatment. The 
bisulfite treatment of DNA converts cytosine residues to uracil whereas the  
C5-methylcytosine residues remain unaffected. The methods described in the analytical step 
can be performed on the altered sequence to retrieve this information. 
 
Alternative approaches are methylation sensitive restriction assays and antibody-based affinity 
purification. Methylation sensitive restriction assays involves the use of restriction enzymes 
that cut DNA if nucleobases are not methylated. Such systems are limited to enzyme 
recognition sequences (Bird and Southern, 1978). Antibody-based affinity purification is 
particularly effective for regions with a higher density of potentially methylated CpG sites 
(Wilson et al., 2006; Weber et al., 2005; Kern et al., 1991).  
Furthermore, there is an immense amount of ongoing industrial research for DNA methylation 
detection. Epigenomics’ diagnostic kits for early cancer detection based on DNA methylation 
patterns, Roche’s chromatin immunoprecipitation sequencing (ChIP), Qiagen’s EpiTect 
Introduction 
 
7 
 
bisulfite conversion kit and Diagenode’s monoclonal antibody products for antibody-based 
affinity purification are examples of industrial applications. 
 
1.4 Enzyme-mediated labeling technologies through cofactor engineering  
Redesigning enzyme catalysis is of general interest in biotechnology and chemical biology. 
Enzymes often possess a certain level of substrate promiscuity. This can be utilized to expand 
the catalytic scope to non natural substrates. Carefully designed cofactor analogs can be used 
to trick the enzymes and lead to new useful transformations. Enzyme-mediated labeling 
through cofactor engineering has been used for different biopolymers such as proteins, 
carbohydrates and DNA. 
 
1.4.1 Protein and carbohydrate Labeling 
Comprehensive understanding of biological systems often needs protein and carbohydrate 
labeling methods to investigate cellular processes in vitro as well as in their native 
environments. Commonly, genetic fusions with fluorescent proteins, e.g. green fluorescent 
protein (GFP) (Tsien, 1998), are used for cellular imaging of proteins and excellent results can 
be achieved. GFP consists of 238 amino acids residues and there are several potential 
disadvantages in using fluorescent protein fusions. These include possible structural 
perturbations or steric hindrance of protein interactions, low fluorescent brightness and low 
photostability. Thus, other approaches for site-specific protein labeling are of interest  
(Marks and Nolan, 2006). 
Covalent protein labeling within cells can be achieved by fusion with the human DNA repair 
protein O
6
-alkylguanine-DNA alkyltransferase (hAGT) (Keppler et al., 2003). This protein 
naturally transfers the methyl group from the damaged nucleobase O
6
-alkylguanine in DNA 3 
to a cysteine residue within its active site resulting in self modification and inactivation 
(Scheme 4A). Importantly, hAGT also serves as a substrate to accept a benzyl group from  
O
6
-benzylguanines 4, even if not a residue in DNA, which provides a basis for the use of 
engineered benzyl analogs (Scheme 4B). Several substrate analogs with additional biotin or 
fluorophores attached to the benzyl group of O
6
-benzylguanine have been synthesized and 
used to label hAGT fusion proteins in vitro and in vivo. This system called SNAP-tag is very 
versatile in terms of molecular labels. In a recent study a mutant hAGT was selected that 
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accepts O
6
-benzylcytosine derivatives and used in combination with the SNAP-tag to perform 
simultaneous two-color labeling in cells (Gautier et al., 2008). 
The hAGT protein is still quite large (about 200 amino acid residues) which makes the 
development of shorter peptide tags interesting. Very recently, lipoic acid ligase (LplA) was 
employed to label cell surface proteins with reporter molecules. LplA from Escherichia coli 
catalyzes an adenosine triphosphate-dependant covalent ligation of lipoic acid 5 with specific 
lysine residues in three proteins involved in oxidative metabolism (E2p, E2o and  
H-protein) (Scheme 4C) (Green et al., 1995). Besides its high peptide sequence specificity, 
this enzyme shows a pronounced promiscuity for lipoic acid analogs. Several carboxylic acids 
containing a terminal azide or alkyne were tested and 8-azidooctanoic acid 6 was found to be 
the best substrate among the tested lipoic acid analogs (Scheme 4D). In addition, a  
22-amino-acid recognition sequence for LplA was designed and genetically fused to cell 
surface proteins. After expression of the cell surface fusion protein the peptide tag was 
modified with an azide by incubation with 8-azidooctanoic acid 6 and LplA and then 
fluorescently labeled in a strain-promoted 1,3-dipolar cycloaddition with cyclic alkynes 
(Agard et al., 2006). 
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Scheme 4: Protein labeling with synthetic substrates for human O6-alkylguanine-DNA 
alkyltransferase (hAGT) and lipoic acid ligase from Escherichia coli (LplA). A) Natural methyl 
group transfer from damaged O6-alkylguanine in DNA 3 to a specific cysteine residue within 
the active site of hAGT. Note that hAGT becomes inactive after covalent self-modification.  
B) Genetic fusion of hAGT to a target protein and direct transfer of a label (gray sphere) 
attached to the benzyl group of O6-benzylguanines 4, which serve as substrate analogs for 
hAGT. C) Natural ligation of lipoic acid 5 with a specific lysine residue within the natural 
substrate dihydrolipoamide acetyltransferase subunit (E2p) of the pyruvate dehydrogenase 
complex by LplA. D) Ligation of the lipoic acid analog 6 containing an azide function to a 
short recognition sequence for LplA genetically fused to a target protein. The bioorthogonal 
azide function can be selectively modified in a second step with reporters containing alkynes. 
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Glycosylation of proteins and lipids participates in central biological events inside and outside 
the cell. This makes glycans attractive targets for imaging their localization, trafficking, and 
dynamics by labeling. The complex glycan structures are assembled by glycosyltransferases 
(GT), which transfer nucleotide donor sugar to acceptor sugars. GT show some degree of 
substrate promiscuity which has been utilized for GT-mediated tagging of glycoconjugates. 
For example, uridine 5’-diphospho- -D-galactose (UDP-Gal, 7) acts as donor sugar for 
various galactosyltransferases (GalT) and the human 3GalT5 transfers the galactose residue 
to N-acetyl-D-glucosamine (GlcNAc) forming Gal( 1-3) GlcNAc structures (Scheme 5A). 
This enzyme and some other GalTs were also able to transfer the biotinylated UDP-Gal 
analog 8 leading to labeling of the formed glycan attached to the test protein bovine serum 
albumin (BSA) (Scheme 5B) (Butler et al., 2001). 
 
 
 
Scheme 5: Carbohydrate labeling with a synthetic substrate for the human 
galactosyltransferase β3GalT5. A) Natural transfer of galactose from the donor  
uridine 5′-diphospho-α-D-galactose (UDP-Gal, 7) to the acceptor N-acetyl-D-glucosamine 
conjugated to bovine serum albumin (BSA). B) Analogous enzymatic reaction with the 
biotinylated UDP-Gal analog 8 leading to direct biotin labeling of the glycoconjugate. 
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1.4.2 DNA labeling 
Enzymatic labeling of DNA is typically performed with modified deoxynucleoside 
triphosphates (dNTPs) carrying reporter groups attached to their nucleobases. Incorporation of 
the modified nucleotides is mostly achieved by DNA polymerases, which often show a 
pronounced tolerance towards chemical groups at the 5 position of pyrimidines and the 7 
position of purines (deazapurines). There are three main labeling methods when using DNA 
polymerases: Random-primed labeling, nick-translation and polymerase chain reaction. 
Alternatively, terminal deoxynucleotidyl transferase can be used to append the 3’ ends of 
DNA with labeled dNTPs. Although very powerful, these methods do not provide  
sequence-specific labeling of native DNA. Bearing in mind the size of DNA and the 
recurrence of only a small number of monomeric units, sequence-specific labeling is a 
challenging task. 
 
1.4.3 Sequence-specific Methyltransferase-Induced Labeling of DNA (SMILing DNA)  
Sequence-specific Methyltransferase-Induced Labelling of DNA (SMILing DNA) is a 
technology at the interface of chemistry and biology (Pljevaljcic, 2002). Nature-inspired novel 
cofactors are tailored by synthetic methods and attached to DNA by highly sequence-specific 
DNA MTases (Pljevaljcic et al., 2003; Pljevaljcic et al., 2004a; Pljevaljcic et al., 2004b). The 
methyl group is not an attractive reporter group therefore transfer of larger chemical entities 
are preferred. The natural cofactor AdoMet (1) is engineered by replacing the methionine side 
chain with an aziridinyl group. Reporter groups can be attached to the adenine ring  
(Scheme 6, black sphere) leading to covalent modification of DNA with fluorescence and 
affinity labels. Overall, SMILing DNA provides a sequence-specific, covalent, quantitative 
and versatile method for DNA labeling (Scheme 7) and has been used for different 
applications (Schmidt et al., 2008). 
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Scheme 6: DNA methylation in nature (right) and labeling of DNA (SMILing DNA) by 
aziridine cofactor analogues (left). Major difference between the natural cofactor AdoMet (1) 
and the synthetic aziridine cofactors is that the DNA MTase-catalyzed nucleophilic attack of 
adenine or cytosine residues in DNA on the activated methyl group of AdoMet (1) results in 
methyl group transfer whereas nucleophilic attack on the aziridine ring leads to ring opening 
and coupling of the whole cofactor to the target nucleobase. The reporter groups  
(black sphere) can also be attached to the adenine ring leading to covalent modification of 
DNA with fluorescence and affinity labels.  
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Scheme 7: SMILing DNA provides a sequence-specific, covalent, quantitative and versatile 
method for DNA labeling. A) Electron microscopy of R.XmnI-linearized pUC19 plasmid 
biotinylated with aziridine cofactor 8BAz using M.TaqI, and treated with streptavidin 
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(Pljevaljcic et al., 2007). Single DNA strand with four streptavidin molecules bound to the 
biotinylated M.TaqI recognition sequences (arrows with letters). B) Depiction of DNA attack 
onto the aziridine cofactor catalyzed by DNA MTase. Labeling reaction produces a covalent 
bond (highlighted in blue). C) DNA protection assay (Pljevaljcic et al., 2007) to analyze 
labeling of R.EcoRI-linearized pUC19 plasmid with cofactor 8BAz (red arrow) using M.TaqI 
(5’-TCGA-3’ recognition sequences indicated by red boxes). After the indicated reaction 
times at 60 °C the DNA was challenged with R.TaqI and cleavage was analyzed by agarose 
gel (1%) electrophoresis and ethidium bromide staining. Full protection against cleavage by 
R.TaqI was obtained after 3-5 h. Control incubations (5 h at 60 °C) in the absence of cofactor 
8BAz or M.TaqI did not lead to DNA protection. D) SMILing DNA can be used with aziridine 
cofactors modified at 6, 7 or 8 position depending on the tolerance of the used enzyme. 
Affinity tags or fluorescent labels (black spheres) are transferred to the target DNA. The 
method is also versatile in regard to the used enzyme. Variable enzymes modify different 
sequences to broaden the target spectrum. 
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1.5 Road Block approach for DNA methylation detection 
SMILing DNA offers a delicate way to detect DNA methylation. The novel detection system 
is based on amplification differences of methylated DNA vs. non-methylated DNA after 
labeling with the SMILing DNA technique. Non-methylated sequences will be labeled with 
the novel aziridine cofactor and a DNA MTase. The rigid structure of the attached cofactor 
(Road Block) is designed to block DNA polymerases and to delay the overall PCR 
amplification whereas methylated DNA can not be modified leading to regular amplification 
(Scheme 8).  
 
 
 
Scheme 8: Schematic representation of the Road Block concept for a new DNA methylation 
detection method; only non-methylated recognition sequences (left) will be modified and 
block PCR amplification. Methylated DNA sequences can not be modified by DNA MTases 
resulting in regular PCR amplification. 
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2. Aim of the projects 
The major aim of the projects is to synthesize novel cofactors for SMILing DNA and broaden 
the spectrum of SMILing DNA applications.  
The projects are classified into three groups: 
1. Synthesis of novel aziridine cofactor for DNA methylation detection 
2. Synthesis of a fluorescent cofactor for DNA labeling 
3. SMILing DNA applications (vide infra) 
The first project’s main objective is to create novel aziridine cofactors that can carry a rigid 
function to DNA by SMILing DNA. After labeling, DNA strands will be amplified by PCR. 
The sequence-specifically transferred rigid function on the non-methylated DNA strands will 
allow the differentiation of methylated vs. non-methylated sequences by delaying the 
amplification (Road Block concept, s. 1.5). 
So far three positions of the aziridine cofactors have been furnished with fluorescent labels 
and affinity tags by former coworkers (Scheme 7D). These cofactors have been used with 
DNA MTases to transfer functionalities in a sequence-specific manner. However, none of 
these contained the satisfactory rigid function that could effectively block the DNA 
polymerase enzyme during the PCR amplification. Furthermore, the function must be bound 
to DNA covalently because weaker interactions (such as biotin-streptavidin interaction) may 
possibly be disrupted during the PCR denaturation step. Due to a short envisioned synthetic 
route, the 6 position on the aziridine cofactor is chosen to conjugate the rigid unit. It contains 
the aziridine part as an electrophile, the sugar and base as a recognition unit for the enzymes 
and a flexible amine linker, which can be further conjugated. 
Poly(paraphenyleneethynylene) (PPE) polymers (Bunz, 2000) are selected as a model for the 
design of the rigid function. PPE is a rigid, fluorescent and -conjugated polymer. It can be 
easily solubilized in water by attaching ionic side chains for biological applications.
 
In 
addition, the ends of the polymer derivative can be post-modified with carboxylic acid groups
 
providing a basis for coupling with the primary amine on the aziridine cofactor. As the length 
of the rigid molecule is an important parameter, different lengths will be produced to optimize 
the blocking. Smaller molecular weights are preferred because they allow higher cofactor 
concentrations needed for the SMILing DNA applications without a massive increase of 
material. 
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Several DNA MTases were used with different aziridine cofactors (Schmidt, 2004) to target 
various DNA sequences. The prokaryotic and eukaryotic DNA MTases were employed to 
label short duplex oligodeoxynucleotides and plasmid DNA. M.TaqI is a good candidate for 
initial labeling experiments of short duplex oligodeoxynucleotides and plasmid DNA because 
it tolerates a wide variety of aziridine cofactors. For detection of CpG DNA methylation in 
humans, cytosine-specific DNA MTases such as M.HhaI and M.SssI could be used. 
The second project’s aim is to synthesize a fluorescent aziridine cofactor for DNA labeling 
studies. The other projects are classified as the SMILing DNA applications (vide infra). Most 
of the projects were performed in collaboration with partner research institutes.  
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3. Results and Discussion 
3.1 Novel aziridine cofactor 6RBAz to detect DNA methylation 
3.1.1 Design of the novel cofactor 6RBAz 
The novel cofactor 6RBAz (29) was designed and synthesized. It contains two separate units; 
rigid and recognition unit (Scheme 9). These two units were attached to each other by peptide 
bond (brown). The properties of the units were designed to meet the requirements for the 
Road Block application (s. 1.5). 
Properties of the rigid unit: 
1. Rigidity: The aromatic phenylene units are connected in the 1 and 4 positions to the 
acetylene units (orange) to form a rigid and linear structure which can not bend. 
2. Polarity: The side-chains are tailored with polar sulfonate (blue) units to enable the 
compatibility with aqueous conditions. 
3. Carboxylic acid end group: The end groups of the unit are furnished with carboxylic 
acid groups to attach the recognition unit by robust peptide coupling method. 
4. Fluorescence: The conjugated system also offers fluorescence properties that could be 
used as a cross-checking measure. 
Properties of the recognition unit: 
1. Recognition: The structure of the recognition unit is an analog of natural cofactor 
AdoMet (1). The use of it with the DNA MTases in SMILing DNA applications are 
very well established (Schmidt et al., 2008). 
2. Amine linker: The four sp3-carbons on the amine linker (green) present a degree of 
flexibility for easy fitting to the cofactor-binding pocket of DNA MTases. In addition, 
a primary amine can be used with a carboxylic acid for peptide coupling. 
3. Electrophilicity: The aziridine ring (red) acts as an electrophile when it is protonated. 
This enables the nucleophilic attack of the DNA base during the enzymatic catalysis of 
DNA MTases. It is also stable under basic conditions. 
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Scheme 9: The structure and characteristics of the novel aziridine cofactor 6RBAz (29). 
 
3.1.2 PPEs: Properties, applications and syntheses 
Poly(paraphenyleneethynylene) (PPE) is a class of conjugated polymers that is rigid, 
fluorescent, π-conjugated and can be easily solubilized in water by adding ionic side groups. 
The PPE term originates from its backbone that consists of alternating linkage of phenylene 
units in the 1 and 4 positions with acetylene groups (i.e. ethynylene units). More general term 
poly(aryleneethynylene) is used for other aromatic or heteroatomic moieties incorporated in 
the backbone. Different ionic groups such as carboxylic, sulfonic (Pinto and Schanze, 2004), 
ammonium or phosphonate moieties have been grafted on the side chains of these conjugated 
polymers as well as neutral groups such as sugars (Disney et al., 2004), highly branched 
alcohols (Wilson et al., 2003) or ferrocenes. These polymers can have high fluorescence 
quantum yields in aqueous solution, they can interact electrostatically with other charged 
species, and they display an extraordinarily high sensitivity to fluorescence quenchers 
(picomolar level) because of the “molecular wire effect” (Zhou and Swager 1995;  
Swager, 1998). Due to their rigidity, they are termed as “molecular rods” in the literature. 
PPEs have found many applications in materials research such as polymeric light-emitting 
diodes (Bunz, 2000) as well as in biosensor technologies (Kim et al., 2005; You et al., 2007). 
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Recently PPEs have been topic of an increasing number of publications because of their 
exceptional rigid character and optical properties (for comprehensive reviews see: Bunz, 
2000; Giesa, 1996; Thomas et al., 2007). 
PPEs can be easily synthesized by Pd-catalyzed Heck-Cassar-Sonogashira-Hagihara reaction 
(Sonogashira et al., 1975; Chinchilla and Najera, 2007). The more common name 
Sonogashira coupling will be used for simplicity throughout the thesis. The C-C bond 
formation occurs between terminal alkynes and aromatic bromides or iodides in the presence 
of amine (Scheme 10).  
 
 
 
Scheme 10: Schematic overview of the Sonogashira coupling reaction. Adapted from Bunz, 
2000. 
 
The generally accepted mechanism is depicted in Scheme 11. The active catalyst for the 
reaction is Pd
0
. In its oxidized form, it is inactive. In the first step, the oxidative addition 
forms the Pd
2+
 intermediate I, which leads to the diorgano-Pd specie II after transmetallation. 
The last step is the reductive elimination, which generates the product along with the active 
catalyst that is used in the next catalytic circle.  
The choice of the following elements is essential to adjust the properties of the outcome: 
 Choice of halide: Both bromo and iodo aromatic compounds are reported to work in 
this reaction. However, all of the reported couplings (involving aryl bromides) have to 
be conducted at elevated temperatures. The coupling with the iodo aromatic 
compounds can be carried out under mild conditions. Obviously, this will decrease 
undesired side-products such as homo-couplings or defect formations.  
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Scheme 11: Schematic representation of Sonogashira coupling mechanism. Adapted from 
Chinchilla and Najera, 2007. 
 
 Choice and amount of catalyst and role of the Cu cocatalyst: Usually two 
commercially available Pd catalysts; tetrakis(triphenylphosphine)palladium(0) and 
dichlorobis(triphenylphosphine)palladium(II) are used. The latter one is the inactive 
form and activated in the course of the reaction. PPh3 is added to stabilize the Pd
0
 
species generated during the catalytic cycle when Pd(II) is used. The use of Pd(II) is 
reported to create diyne defects consuming some of the alkynes thus changing the 
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stoichiometry of the reactants. This is especially important to produce high molecular 
weight polymers. 
 CuI serves as a cocatalyst in the reaction. It is important to facilitate the substitution 
reaction of reactants through the reductive elimination (Sonogashira et al., 1975). 
However, there are recent studies showing Sonogashira coupling conditions without 
copper salts (Soheili et al., 2003). The goal of these studies is to avoid the side 
reactions like homocoupling products of the terminal alkyne (the so-called Glaser 
coupling) in the presence of air. Air presence oxidizes the active Pd
0
 catalyst to the 
inactive form, and therefore the reaction should be performed under inert atmosphere. 
 The reported amount of Pd and Cu vary from original conditions 10% Pd(II), 5% CuI 
to much lower amounts. It is also beneficial to check the successful start of the 
reaction by the increase of turbidity of the reaction mixture, indicating the formation 
of insoluble ammonium halides (Scheme 11, highlighted red). For this, very small 
amounts of CuI may be increased until the above-explained observation occurs. 
 Choice of amine and solvent: The use of diisopropylamine as a base for effective 
polymer formation was emphasized (Bunz, 2000). It is desirable to add a cosolvent to 
ensure solubility of the formed polymer. Polar cosolvents are employed for water 
soluble PPEs. 
 Choice of substituents on halophenylene: The active Pd catalyst is an electron-rich 
specie therefore the oxidative addition step is influenced by the nature of substituents 
(Scheme 10, R1) on the aromatic nucleus. More electron-withdrawing R1 leads to 
faster oxidative addition of the electron-rich Pd
0 
specie. 
 Choice of stoichiometry and concentration of reactants: The stoichiometry of 
reactants is essential and it should be well adjusted for successful coupling. Higher 
concentrations accelerate the reaction to ensure fast coupling, however cooling may be 
necessary for large scale reactions.  
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3.1.3 Synthetic strategies for the rigid unit 
3.1.3.1 Synthesis of the water soluble diiodo monomer 
Diiodo monomer 12 is one of the two building blocks for the rigid unit (Scheme 12). It has an 
aromatic backbone furnished with anionic side chains. The sulfonic acid groups provide a 
good level of polarity. Their high acidity allows working at lower pH values. The iodine 
atoms at the 1 and 4 position are selected to undergo Sonogashira couplings under mild 
conditions. The synthetic route for 12 consisted of three steps. The starting material  
1,4-dimethoxybenzene (9) is commercially available. The ortho-para positions were modified 
with iodine by using an excess of iodine monochloride (ICl) (Wariishi et al., 2003). ICl in 
methanol yielded better results than other literature reactions such as molecular iodine-iodic 
acid in sulfuric acid system. Methanol as a solvent was crucial because it favored iodination 
over chlorination. Resulting 10 was deprotected by a Lewis acid to yield  
2,5-diiodobenzene-1,4-diol (11). In the last step the sulfonic acid side chains were placed on 
both hydroxyl groups by reacting with 1,3-propanesultone under basic conditions  
(Tan et al., 2002). 1,3-Propanesultone was dissolved in dioxane which seemed to be necessary 
because the reaction did not proceed without it.  
 
 
 
Scheme 12: Scheme for the synthesis of monomer 12 of the rigid unit.  
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3.1.3.2 Direct Sonogashira coupling 
Rigid unit 19 (Scheme 13) contains the previously explained requirements (see 3.1.1). The 
polarity results from the sulfonic acid side chains on the monomer 12. The rigidity is provided 
by the conjugated system comprised of three aromatic benzenes connected with ethynylenes 
in the 1 and 4 positions. The carboxylic acid ends originating from the second monomer 17 
can be activated for peptide coupling.  
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Scheme 13: Scheme for the synthesis of rigid unit 19 by direct Sonogashira coupling. 
 
The two-step synthesis of the second monomer 17 started with the Sonogashira coupling of  
4-iodobenzoic acid (15) with the ethinyltrimethylsilane (TMS) to form  
4-((trimethylsilyl)ethynyl)-benzoic acid (16) (Scheme 13). Acidic work-up conditions were 
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necessary to neutralize the amine and to ease the DCM/H2O separation by protonation of the 
carboxylic acid. Acetic acid was found to be effective for this. More powerful acids could 
have been harmful to the integrity of the compound. Afterwards, the ethinyl group was 
deprotected under basic conditions. This monomer 17 was reacted with the first monomer 12 
under similar Sonogashira coupling conditions (condition for the formation of 16) except for 
the more polar DMF/H2O solvent system. The progress of the reaction was monitored by the 
intense blue fluorescence when illuminated with a near-UV lamp. The product was 
recrystallized under similar conditions prepared for PPE-SO3 polymers (Tan et al., 2002). 18 
was almost insoluble in organic solvents. As this solubility was required for the peptide 
coupling, sodium was exchanged to triethylammonium through cation exchange 
chromatography to enable solubility in DMF, DMA and DMSO.  
Special emphasis should be given to the analytic studies of 18 and 19. NMR of 18 in 
deuteriated water gave broad peaks and poor multiplicities. In contrast, 19 in deuteriated 
DMSO gave far better results. Besides the evident better signal/noise ratio and multiplicities, 
the signals from the counter-ions could be monitored. The amount of triethylammonium 
counter ion was found to be two. They are probably located at the sulfonic acids due to its 
higher acidity compared to the carboxylic acids. 
As far as the ESI-MS was concerned, special measuring conditions were needed to obtain 
results. The acidic nature of the side chains required the negative ion mode. NaOH (0.1M) 
showed the best measuring conditions for 18 whereas the water/acetonitrile (1:1) solution 
system worked for 19. 
 
3.1.3.3 Stoichiometric Sonogashira coupling 
Longer molecules consisting of more monomer units in the backbone required special 
elongation strategies. Elongation and polymerization reactions under imbalanced 
stoichiometry were used by other research groups (Zhao et al., 2003, Zhao et al., 2008). The 
stoichiometric Sonogashira coupling strategy was based on the effect of reactant ratios on the 
statistical distribution of products. Principally, the ratio of the reactants should lead to the 
formation of the desired product. The side products could be removed by RP-HPLC 
purification.  
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Scheme 14: Schematic representation of stoichiometric Sonogashira coupling strategy. The 
rational design of the reactant ratio for Sonogashira coupling reaction can statistically lead to 
the desired major product. Undesired side products can be removed by RP-HPLC 
purification. 
 
For the desired product two eq. of 15, one eq. of 12 and two eq. of 14 were reacted under 
Sonogashira coupling conditions (Scheme 14). 32 was isolated by RP-HPLC purification. The 
difficulties arose mainly during the purification step. HPLC purification was cumbersome, 
labor intensive and produced relatively low amounts. On the other side, isolated 32 was ready 
to use for the peptide coupling reaction with the recognition unit because it was soluble in 
organic solvents such as DMF, DMA and DMSO. Cation exchange of the side chains 
occurred directly during HPLC purification in the presence of TEAHCO3 buffer. 
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3.1.3.4 Controlled extension 
The controlled extension of phenyleneethynylenes and aryleneethynylenes were studied by 
research groups (Morin et al., 2007; Lo et al., 2007). For instance, Shirai et al. synthesized 
oligo-(phenylene ethynylene)s as chassis and alkynyls as axles in their nanovehicle design 
(Shirai et al., 2006). The main difference between the oligomer and polymer synthesis of the 
phenyleneethynylenes is the protection group requirement. One of the reactive groups should 
be selectively protected to provide the Sonogashira coupling on only one side. The protection 
of ethynylenes can be accomplished by using trimethylsilyl (TMS) and triisopropylsilyl 
(TIPS) groups (for review see Nelson et al., 1996). When they are both employed their 
selective deprotection by pH adjustment is also possible (Sasaki et al., 2008).  
The design of the controlled extension approach was based on the one-sided reaction of 12 
with a trimethylsilylacetylene (TMSA) group (Scheme 15). The selective reaction of 
diiodobenzene with TMSA was shown below (Balavoine et al., 2007). Selective protection 
could be followed by coupling with 14. Afterwards the extension could be either terminated 
by deprotection and end modification with 15 or further extended with commercially available 
38 to add two aromatic units to the backbone (Scheme 16). 
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Scheme 15: Schematic depiction of controlled extension. The initial reaction of one iodide on 
12 with trimethylsilylacetylene (TMSA) could be followed by coupling with 14 to form the 
basis structure 37 for the controlled extension. 
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Scheme 16: Schematic illustration of controlled extension approach. The compounds can be 
either reacted with 15 to produce the rigid unit or can be extended by two more aromatic 
units. 
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The Sonogashira coupling reaction of 12 with 1.1 eq. of TMSA in the presence of 
triethylamine, DMF and Pd/CuI was monitored by RP-HPLC (Scheme 17). The UV 
absorption maximum of starting material (300 nm) and TMSA (265 nm) were selected for 
detection. The starting material was observed to be almost completely consumed after 2 d. At 
the same time a new peak formed after 3.5 h. After 2 d the new peak became the major 
product absorbing mainly at 265 nm. The UV absorption and polarity profile of the new major 
peak matched with the properties of the desired product 36. However, the isolated product 
could not be characterized by mass spectroscopy. The other two minor peaks were 
presumably related to the two-sided reaction and deprotection of TMS group under basic 
buffer conditions. 
 
 
 
Scheme 17: Selective protection of 12 and RP-HPLC analysis of the reaction. Reaction of 12 
with 1.1 eq. of TMSA under Sonogashira conditions formed 36. Starting material 12 was 
completely consumed after 2 d. Chromatograms detected at 300 nm (left) and 265 nm (right) 
are shown in the same scale with time axes. 
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3.1.3.5 Extension through polymerization 
The polymerization conditions for the high molecular weight PPE-SO3 polymers were 
described in Tan et al., 2002. As the low molecular weights allow higher cofactor 
concentrations needed for SMILing DNA applications, the conditions of the polymerization 
reaction were reviewed. The listed elements in 3.1.2 were readjusted to produce the desired 
low molecular weights. Mainly the stoichiometric balance of the reactants was changed by 
reducing the solubility of 12. The imbalanced reactants stoichiometry was achieved by using 
THF as a reaction solvent at room temperature which dissolved 12 only partially. The 
resulting 34 was characterized by NMR end group analysis. UV absorption spectra showed 
UVmax of 370 nm, which was an indicator of lower molecular weights. 
Although 34 with lower molecular weight was obtained (four repeating units according to 
NMR end group analysis) the low reaction yield made this approach unfeasible to continue 
with further end modification (Scheme 18). 
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Scheme 18: The depiction of the extension through polymerization approach. The two 
monomers 12 and 14 were used to produce the polymer. Resulting polymer’s end group can 
be functionalized by another Sonogashira coupling with 17 to obtain the desired rigid unit.  
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Furthermore, the published favored polymerization conditions (Tan et al., 2002) were tested 
as a control. The reaction took place with a balanced stoichiometry, at elevated temperature 
and PPE polymer (33) was isolated for characterization. The 
1
H-NMR end group analysis 
showed about 20 repeating units. 33 was further characterized by GPC (water) analysis. The 
measured molecular weight (number average) was not concomitant with the 
1
H-NMR end 
group analysis. This molecular weight difference between these two characterization methods 
was also reported in the literature (Bunz, 2000). The flexible nature of polystyrene as a 
calibration material was reported to cause big deviations compared to the 
1
H-NMR end group 
analysis. RP-HPLC analysis (Figure 1) showed a single peak with a similar UV absorption 
character to the published data (Tan et al., 2002). 
The isolated compound was attempted to couple to 4-ethynylbenzoic acid (17) to furnish the 
compound with a carboxylic acid function (Lee et al., 2006). The resulting compound showed 
no change on the end groups by 
1
H-NMR. Same end group coupling without isolating 33 led 
to similar results. 
 
 
 
Figure 1: RP-HPLC analysis of the PPE polymer (33) obtained with balanced stoichiometry. 
The 440 nm absorbance was selected according to the UVmax of 33. The rest of the 
chromatogram showed no significant signals. 
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3.1.4 Synthesis of the recognition unit 
The synthesis of the aziridine cofactor analogs substituted at 7 and 8 positions (see Figure 2 
for numbering) was developed by former researchers from Weinhold group (Schmidt, 2004). 
Another position to attach a flexible linker to the aziridine cofactor is the exocyclic amino 
group (Schmidt et al., 2008). 26 has an aziridine ring to act as an electrophile under slightly 
acidic conditions. Sugar and base are analogous to the natural cofactor AdoMet (1) and the 
amine linker generates a degree of flexibility to locate 26 in the MTase cofactor-binding 
pocket.  
 
 
 
Figure 2: The numbering system for the purine nucleosides. 
 
The synthesis of 26 started with the protection of the 2’- and 3’-hydroxyl groups of 
commercially available 6-chloroadenosine (20, Scheme 19). The hydroxyl groups were 
protected with dimethoxypropane in acetone under acidic conditions (Kappler and Hampton, 
1990). In the second step, the chlor atom of 21 at the 6 position was substituted with a 
diaminobutane linker to yield 22 (Bressi et al., 2000). The dimerization reaction was 
suppressed by keeping diaminobutane in excess during the reaction. However, TLC analysis 
showed a low amount of dimer formation, which was less polar than the desired 22. 22 was 
reacted further with trifluoroethylacetate to protect the primary amine functionality  
(Curphey, 1979). At this point 23 was purified by column chromatography. The 5’-hydroxyl 
group was activated with mesyl chloride. Resulting 24 was very sensitive to temperature and 
even at room temperatures led to a side product as monitored by TLC. To circumvent this 
problem and obtain higher yields the compound was kept at ice-cold conditions during the 
column purification and drying steps. The next step consisted of deprotecting the 2’- and 3’-
hydroxyl groups under acidic conditions by formic acid to yield 25. Then mesylate group was 
substituted by freshly prepared aziridine. Aziridine was prepared from 2-bromoethylamine 
hydrobromide and handled carefully as it is very toxic (Gabriel, 1888). The product 26 was 
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isolated by RP-HPLC with basic elution buffers. This enabled the in-situ deprotection of the 
trifluoroacetamide protection group and also prevented the protonation of the aziridine ring 
which could lead to polymerization (Greene and Wuts, 1991). 
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Scheme 19: The synthetic scheme of the recognition unit 26. 
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However, the low reaction yield of 26 hinted that an intermolecular reaction between the 
aziridine ring and the primary amine could have taken place during reaction or/and 
purification. For the same reason the purification step reduces the lifetime of the RP-HPLC 
columns. It was also observed that lyophilization of 26 led to the same inactive compound 
unless the lyophilization conditions were kept above pH 8 by adding a base. Lastly, repeated 
thawing and freezing of 26 was found to harm the stability of the compound and hence the 
consumption of the compound should be properly planned before use.  
 
3.1.5 Peptide coupling reaction 
The amide bond represents the main chemical bond for the amino acid building block that 
forms the proteins. Besides the biological systems, amide bond formation is a fundamentally 
important reaction in organic synthesis. Peptide coupling reactions have found countless 
applications in academic and industrial organic synthesis research (for examples see 
Montalbetti and Falque, 2005). 
The amide bond is typically synthesized from carboxylic acids and amines. However, the 
condensation reaction does not occur without activation of the carboxylic acid. Carboxylic 
acid can be activated by converting the –OH of the acid into a good leaving group prior to 
treatment with the amine (Scheme 20). 
 
 
 
Scheme 20: Schema of the activation strategy for the amide bond formation. 
 
There are several reported activating agents (peptide coupling reagents) in the literature  
(for reviews see Han, et al., 2004; Valeur and Bradley, 2009). Only the experimented peptide 
coupling reagent classes, their reaction conditions and mechanisms will be discussed in this 
section for simplicity. The used peptide coupling reagents (Figure 3) convert the carboxylic 
acid into an active ester and can be grouped into two classes; carbodiimides with additives and 
uronium salts. 
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Figure 3: The structures of the used peptide coupling reagents and additives. 
 
3.1.5.1 Carbodiimides with aromatic additives 
The carbodiimide reagents have been widely used in peptide coupling reactions  
(for comprehensive review on carbodiimide reagents see Williams and Ibrahim 1981). They 
show a moderate activity and they are reasonably cheap.  
The peptide coupling reaction starts with the activation of the carboxylic acid by the coupling 
reagent DIC (Scheme 21). The resulting 40 can lead to an unreactive side product 41 by a 
rearrangement reaction. In order to reduce the formation of this side product, additives were 
developed by researchers (Carpino, 1993). The additives (HOBt or NHS) compete with the 
side reaction to produce the active esters 42, which can generate the desired amide 44 through 
reaction with the amine. The coupled hydroxysuccinimide ester intermediate can be isolated 
and coupled with the amine under mild conditions. The DIC-HOBt is a commonly used 
combination for in situ activation (Marder et al., 2003). However, HOBt is an explosive 
compound and should be handled with care. The side product urea 43 can be cleaned by 
washing with a suitable solvent or by filtration depending on the reaction conditions. Another 
important point is to adjust and keep a basic pH for the final step as the excess usage of 
additives can cause acidity (pKa 4.60 for HOBt). 
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Scheme 21: Schematic mechanism of carboxylic acid activation by DIC with additives HOBt 
and NHS. 
 
3.1.5.2 Uronium salts 
Another family of peptide coupling reagents is the uronium salts. There are several reagents 
available differing in structure and counter-ion (Montalbetti and Falque, 2005). The coupling 
is achieved by forming the active ester followed by reacting with the amines in a one-pot 
reaction (Scheme 22). The addition of base is essential to ensure the deprotonation of the acid 
and the hindered bases are reported to work well due to their non-nucleophilic nature.  
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Scheme 22: Proposed mechanism of peptide coupling reaction with the uronium salt TBTU. 
 
3.1.5.3 Peptide coupling of recognition (26) and rigid (19) unit 
The rigid unit 19 was coupled with the recognition unit 26 by peptide coupling reaction. 
Firstly, DIC was chosen as a coupling reagent because of its solubility in organic solvents 
such as DMA and DMF. NHS was used along with the DIC reagent (Scheme 21) to produce 
the active ester from 19. With an excess amount of NHS (100 eq.) and DIC (100 eq.) the 
complete conversion of 19 was observed overnight at RT (Scheme 23). The excess use of 
NHS led to acidic pH, which should be avoided during the peptide coupling to assure the 
nucleophilic activity of the amine. Secondly, the excess use of NHS required longer  
RP-HPLC purification time. That is why the resulting activated compound (Scheme 23, 45) 
was prone to decompose to the starting material 19 in the presence of water during RP-HPLC. 
Efforts to characterize the HPLC purified intermediate either by mass or NMR analysis did 
not succeed (data not shown). In order to show the activity of the intermediate it was coupled 
to primary amine 1,4-diaminobutane. The coupling reaction was performed at pH 9 by adding 
DIPA. The desired coupling produced a new peak (Scheme 23, 46) accompanied by the 
intermediate. Unfortunately, no coupling product was observed when the recognition unit 26 
was added to the activated acid. 
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Scheme 23: Synthetic scheme for a test peptide coupling of 19 with DIC and NHS activation 
and RP-HPLC analysis. Reaction 1 shows complete conversion of 19. Addition of  
1,4-diaminobutane converted approximately half of 45 to the new product 46 (analyzed 
amounts varied in experiments). 
 
In addition, control reactions of 19 with only DIC were performed. The formation of 19-DIC 
intermediate could be monitored after 30 min (Figure 4). The isolated peak exhibited similar 
UV absorption character compared to 19 (UV260/365 = 0.33). ESI-MS analysis indicated 
formation of the active or inactive intermediate with one side of the carboxylic acid end 
groups modified (see Scheme 21, 40 and 41). 
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Figure 4: RP-HPLC analysis for the control reaction of 19 with only DIC. ESI-MS analysis of 
19-DIC intermediate indicated formation of the active or inactive intermediate with one side of 
the carboxylic acid end groups modified. 
 
Further experiments to couple 19 with 26 were performed: at 50 
o
C; with more concentrated 
26 lyophilized at basic conditions or in organic solvents such as DMA (verified by  
RP-HPLC). However, neither of the above experiments resulted in product development. 
Successful peptide coupling of 19 with 26 was realized with the TBTU coupling reagent. 
There are few important points about the reaction conditions to emphasize: 
 26 was not further lyophilized to get higher concentrations. The higher concentrations 
and water free conditions were highly desired for the ease of the reaction however, 
lyophilization of 26 in elution buffer (about 50% acetonitrile in 10 mM TEAHCO3,  
pH 8.0 buffer) generated inactive product.  
 DMA was chosen as a solvent for the 19 and the total volume of DMA was set to be 
equivalent to the total volume of the elution buffer of 26. The volume percentage of 
water was kept low to prevent the undesired competition reaction with water.  
 Molecular ratios of 19 to 26 were varied from 1:5 to 1:1. Both ratios were shown to 
work. 26 was added dropwise to prevent possible formation of a two-sided coupling 
product. 
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 Presence of a base is essential in the beginning and during the course of the reaction to 
ensure the basic environment. EDIA was selected as a base because of its hindered, 
non-nucleophilic structure. The pH was kept about 9 during the reaction. 
 RT conditions and overnight reaction time were found to be suitable for the reaction.  
 Order of adding reactants is critical. All reactants must be added before dropwise 
addition of 26 as control reactions otherwise showed no product formation. 
Finally, the coupling reaction of 19 with 26 was monitored by RP-HPLC after one day at RT 
(Figure 5). The chromatogram indicated the formation of the new peaks with a novel UV 
absorption character. The UV absorption at 260 nm increased showing the successful 
formation of the peptide bond (19, UV260/365 = 0.33; 6RBAz (29), UV260/365 = 0.5). The 
retention time of 6RBAz (29) shifted further to the more non-polar region of the 
chromatogram (19, Rt ~ 6 min; 6RBAz (29), Rt = 14.5 − 17 min). The broad signal at  
Rt = 4 − 10 min, 260 nm was due to the excess use of TBTU reagent. The starting material 19 
was almost completely consumed. The chromatogram in Figure 5 eluting between  
14.5 − 17 min shows three peaks with almost identical UV absorption character. Positive ion 
mode LC-MS analysis of the reaction products showed only one sharp product peak instead of 
three (data not shown). The UV character was identical (6RBAz (29), UV260/365 = 0.5). The 
difference was attributed to the better quality of the LC-MS column. The high resolution  
LC-MS analysis confirmed the successful formation of 6RBAz (29). Another interesting 
observation was the absence of a two-sided peptide coupling product. This result was parallel 
with the 19-DIC intermediate (see Figure 4).  
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Figure 5: RP-HPLC analysis for peptide coupling reaction of recognition (26) and rigid (19) 
unit with TBTU. Coupling reaction produced the novel aziridine cofactor 6RBAz (29). 
 
3.1.5.4 Peptide coupling of the recognition unit (26) with elongated rigid unit (32) 
Peptide coupling of 32 with 26 was investigated. DIC and HOBt were selected as coupling 
reagents and DMF as a solvent for activation. 32 was dissolved in DMF. Then excess of DIC 
and HOBt were added respectively at 50 
o
C to stir for 30 min. Excess of 26 was added 
dropwise and reaction was left overnight. RP-HPLC analysis (Figure 6) showed the formation 
of a new product. The new peak showed different polarity and UV absorption character. The 
retention time of the new peaks compared to 32 demonstrated a more non-polar character, 
which can be attributed to the coupling with 26. The coinjection of 32 with the reaction 
mixture proved the novelty of additional peaks. The UV absorption character of the new peaks 
showed higher UV absorbance at 260 nm compared to 32 (UV260/400 = 0.36), which was a 
clear indication of coupling with 26. The second peak at higher retention time illustrated 
similar UV absorption (UV260/400 = 0.53). However, characterization of the isolated peaks 
could not be achieved by mass spectroscopy. 
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Figure 6: RP-HPLC analysis of 32 (UV260/400 = 0.36) coinjected with the peptide coupling 
reaction mixture between 32 and 26. The two wavelengths were selected according to the 
UV absorption character of the starting materials. The significant increase in the 260 nm 
absorption of the two new peaks at retention time 13.5 min – 14 min (UV260/400 = 0.50 and 
UV260/400 = 0.53) indicated the formation of a coupling product. 
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3.2 Novel fluorescent aziridine cofactor 6TAMRAAz  
3.2.1 Synthesis of 6TAMRAAz 
Tetramethylrhodamine (TAMRA) presents an ideal fluorescent tag for DNA labeling studies 
(λex = 546 nm; λem = 575 nm). The fluorophore has relatively high quantum efficiency and 
TAMRA-NHS ester is commercially available to produce facile peptide coupling with amine 
groups (Christie et al., 2009).  
The recognition unit 26 was coupled with TAMRA-NHS (30) under mild conditions. 30 was 
dissolved in DMSO and added to 26 in a water/acetonitrile mixture in 10 mM TEAHCO3 
buffer, pH 8.5 (elution buffer). The reaction was conducted at RT without adding an extra 
base. 
The reaction progress is shown in Scheme 24. After 5 h reaction, the formation of a peak 
around 18 min retention time was observed. This peak demonstrated intense absorption at  
546 nm. The UV absorption ratio of 269 nm to 546 nm in starting material 30 increased from 
0.4 to 0.5 in the expected product 31. Finally, this product was successfully characterized by 
ESI-MS analysis. 
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Scheme 24: Scheme for 6TAMRAAz (31) synthesis and RP-HPLC analysis of the reaction 
progress. The UV absorption 269 nm corresponds to the absorption maximum of 26 whereas 
546 nm corresponds to the absorption maximum of 30.  
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3.3  SMILing DNA applications 
3.3.1 SMILing DNA for photoporation transfection studies 
Laser-assisted cell poration (photoporation) presents a promising method for cell transfection 
studies. It has distinct advantage of cell specificity, while maintaining high transfection 
efficiency, good post-transfection cell viability and overall ease of operation  
(Stevenson et al., 2006). 
The green fluorescent protein (GFP) encoding plasmid DNA (pAcGFP1-N2 encodes GFP 
from Aequorea coerulescens) was selected as substrate for the transfection studies. The entire 
DNA carries 27 recognition sequences for M.HhaI DNA MTase. The SMILing DNA of the 
GFP vector DNA was performed with aziridine cofactor 6TexAz (47) (Figure 7). This 
cofactor was particularly suitable because of its distinct fluorescent properties (λex = 583 nm;  
λem = 603 nm) compared to GFP (λex = 475 nm; λem = 505 nm). 
The restriction-modification analysis showed the successful labeling of the DNA (Figure 8). 
After the labeling of 10 µg plasmid DNA with M.HhaI MTase (modifies the first cytosine in 
the 5’-GCGC-3’ sequence), the restriction enzyme R.HaeII (cuts 5’-R/GCGC/Y-3’; R = A or 
G and Y = C or T) was used to test the labeling. R.HaeII (7 restriction sites) cuts the 
unmodified recognition sites to produce DNA fragments. The SMILing DNA experiments 
with or without restriction showed similar results. The full protection of the plasmid DNA was 
achieved (lane 2 and lane 3). The presence of three bands instead of one could be attributed to 
the different forms of plasmid. Furthermore, control experiments without 6TexAz (47) or 
M.HhaI led to fragmentation in the restriction assay (lane 4 and 6).  
 
 
 
Figure 7: The structure of the fluorescent aziridine cofactor 6TexAz (47). 
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The labeled DNA was delivered to the cooperation partner at “Fraunhofer-Institut für 
Lasertechnik” to conduct the photoporation transfection studies. 
 
 
 
Figure 8: Analysis of labeling pAcGFP1-N2 DNA with cofactor 6TexAz (47) and M.HhaI 
MTase by agarose gel (1%) electrophoresis. The labeling experiment was performed at  
37 oC for 3 h. Then plasmid DNA was heated for at 75 oC 15 min to denaturate M.HhaI. The 
labeled DNA was purified with a QIAprep Spin Miniprep Kit. The degree of labeling was 
examined by restriction analysis with R.HaeII enzyme. Lane 1: DNA ladder 1 (100 ng);  
Lane 2: Labeling reaction followed by incubation with R.HaeII; Lane 3: Labeling reaction; 
Lane 4: Control labeling experiment without 6TexAz (47) followed by incubation with R.HaeII; 
Lane 5: Control labeling experiment without 6TexAz (47); Lane 6: Control labeling experiment 
without M.HhaI followed by incubation with R.HaeII; Lane 7: Control labeling experiment 
without M.HhaI. 
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3.3.2 Amplification of labeled DNA by PCR 
The labeled pAcGFP1-N2 DNA from s. 3.3.1 was further analyzed for PCR amplification. 
Firstly, the labeled and non-labeled DNA were linearized by R.HindIII restriction enzyme 
(cuts 5’-A/AGCT/T-3’; one restriction sequence) to quantify the labeled DNA. It was 
performed by comparing the amount of labeled DNA to pAcGFP1-N2 DNA on an agarose gel 
(Figure 9A). The quantified amount (10 ng) was amplified by PCR to observe the effect of 
labeling with cofactor 6TexAz (47) (Figure 9B). The results showed no significant visible 
difference after 15 and more PCR cycles.  
 
 
 
Figure 9: A) Quantification of the labeled pAcGFP1-N2 DNA (1% agarose gel).  
Lane 2: Labeled DNA restricted with R.HindIII; Lane 3: pAcGFP1-N2 DNA (10 ng) restricted 
with R.HindIII, labeled DNA amount was estimated according to lane 3; Lane 1 and 4 are 
DNA ladder 1 (100 ng).  
B) PCR analyses of linear DNA (10 ng) vs. linear, labeled DNA (10 ng) (PCR program 1). 
The names of the used polymerases (Pfu, Taq, Tth and Vent) are given below the bands. 
Lanes 1: 15 cycles; Lanes 2: 20 cycles; Lanes 3: 25 cycles; Lanes 4: 30 cycles. 
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This experiment did not result in a significant Road Block effect as intended. Thus, another 
DNA polymerase (Pwo polymerase) was tested. For this purpose the plasmid pAcGFP1-N2 
DNA was labeled again with 6TexAz (47) and M.HhaI. 
The degree of labeling and structural analysis of the plasmid is shown in Figure 10. Labeled 
plasmid DNA was purified and incubated with or without the restriction enzyme (lane 3 and 
lane 2). No small DNA fragments are observed in lane 3, which indicates the full protection 
and full labeling of plasmid DNA. In order to study the structural properties of the plasmid, 
the original plasmid was cut by R.HindIII restriction enzyme (lane 4). During restriction, 
DNA was cut once to create linear DNA. The size of the DNA for the three lanes were 
principally same, however the structural properties affected their mobility on the agarose gel. 
Obviously linear DNA (lane 4) had the highest mobility, whereas the plasmids in lanes 2 and 
3 moved in two different forms (theoretically nicked and supercoiled form). 
The concentration of the labeled plasmid DNA was estimated by comparison with the  
non-labeled pAcGFP1-N2 DNA. Variable amounts of plasmid DNA were analyzed to 
compare with the labeled DNA (Figure 11A). Lanes 2 and 4 were found to have very similar 
DNA quantities. It was essential to start the PCR amplification with similar DNA amounts for 
a reasonable comparison. Furthermore, less amplification cycles were used to optimize the 
possible amplification differences. However, the results showed no evidence of a delayed 
amplification. PCR amplification after 4 cycles (Figure 11B, lanes 1) showed no visible 
amplified band. The intensity of the DNA bands after 8 and 12 cycles was difficult to 
distinguish between labeled and non-labeled DNA. The low amount of amplified DNA in  
lane 4 of the non-labeled DNA can be attributed to an experimental error. These results may 
be due to the insufficient rigidity of 6TexAz (47) which emphasize the need for more rigid 
novel aziridine cofactors. 
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Figure 10: Structural analyses of pAcGFP1-N2 DNA labeled with 6TexAz (47) and M.HhaI  
(1% agarose gel). Lane 1: DNA ladder 1 (10 ng); Lane 2: Labeling followed by QIAprep Spin 
Miniprep Kit purification; Lane 3: Labeling followed by QIAprep Spin Miniprep Kit purification 
and incubation with R.HaeII; Lane 4: Non-labeled DNA restricted with R.HindIII;  
Lane 5: Non-labeled plasmid DNA; Lane 6: DNA ladder 1 (40 ng). 
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Figure 11: The illustration of concentration (A) and PCR (B) analyses of DNA labeled with 
6TexAz (47) and M.HhaI. 
A) The concentration analyses of labeled pAcGFP1-N2 DNA vs. non-labeled plasmid DNA 
(1% agarose gel). Lane 1: DNA ladder 1 (100 ng); Lane 2: Labeling followed by QIAprep Spin 
Miniprep Kit purification; Lane 3-6: 63.5 ng, 127 ng, 254 ng, 508 ng pAcGFP1-N2 DNA;  
Lane 7: DNA ladder 1 (50 ng).  
B) The PCR analyses of the labeled pAcGFP1-N2 DNA vs. non-labeled plasmid DNA  
(1.2% agarose gel). Pwo DNA polymerase was chosen for the amplification.  
Lanes 1-4: Amplification of labeled and non-labeled plasmid DNA after 4, 8, 12, 16 cycles 
respectively (PCR program 2). 
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3.3.3 Quantitative labeling of long plasmid DNA with nanometer precision 
Sequence-specific labeling of native DNA is fundamental for functional studies of DNA, 
DNA modifying enzymes, nanobiotechnology and medical diagnostics. Sequence-specific 
labeling of DNA is however a very challenging task (Dervan, 2001; Weller and Rajski, 2006). 
SMILing DNA offers a neat way of labeling DNA sequence-specific, covalent, quantitative 
and versatile. 
The labeling reaction of linearized pUC19 DNA with M.TaqI DNA MTase and 8BAz 
cofactor (48) (Figure 12) was examined in this application. Firstly, the plasmid DNA pUC19 
was linearized with R.XmnI restriction endonuclease (cuts 5’-GAANN/NNTTC-3’, one 
restriction site in pUC19, Figure 13A) which yielded a fragment with the expected length. 
However, linearized pUC19 DNA possessed an almost identical electrophoretic mobility 
compared to the untreated, presumably supercoiled plasmid. To resolve this ambiguity, the 
linearization experiment was further investigated by cutting with R.HindIII (1 restriction site). 
Agarose gel electrophoresis analysis showed the further successful fragmentation of the DNA 
(Figure 13B) and the two visible fragments migrated at the right location. 
 
 
 
Figure 12: The structure of cofactor 8BAz (48). 
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Figure 13: Agarose gel electrophoresis (1%) of linearized pUC19 DNA.  
A) The linearization experiment with R.XmnI. Lane 1: DNA ladder 1 (80 ng); Lane 2: Plasmid 
pUC19 DNA (50 ng); Lane 3: Plasmid pUC19 DNA (100 ng); Lane 4: R.XmnI-linearized 
pUC19 DNA, batch 1 (80 ng); Lane 5: R.XmnI-linearized pUC19 DNA, batch 1 (160 ng);  
Lane 6: R.XmnI-linearized pUC19 DNA, batch 2 (64 ng); Lane 7: R.XmnI-linearized pUC19 
DNA, batch 2 (128 ng); Lane 8: DNA ladder 1 (50 ng). The DNA samples in lane 4-7 were 
purified by QIAprep Spin Miniprep Kit before analyzed by gel electrophoresis. The DNA 
amounts after the QIAprep Spin Miniprep Kit purification was quantified according to the DNA 
ladders. The hand-written numbers shows the DNA amounts (ng) on specific ladder bands. 
B) Fragmentation of R.XmnI-linearized pUC19 DNA with R.HindIII (1% agarose gel).  
Lane 1: DNA ladder 1 (50 ng); Lane 2: R.XmnI-linearized pUC19 DNA (purified by QIAprep 
Spin Miniprep Kit, batch 1, 80 ng) treated with R.HindIII enzyme; Lane 3: R.XmnI-linearized 
pUC19 DNA (purified by QIAprep Spin Miniprep Kit, batch 2, 64 ng) treated with R.HindIII 
enzyme; Lane 4: Plasmid pUC19 DNA (100 ng). The numbers in yellow shows the length of 
DNA bands in base pairs (bp). 
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Figure 14: Agarose gel electrophoresis analysis of labeling R.XmnI-linearized pUC19 DNA 
with 8BAz (48) and M.TaqI (1% agarose gel). Lane 1: DNA ladder 1 (50 ng); Lane 2: Labeling 
of R.XmnI-linearized pUC19 DNA with 8BAz (48) and M.TaqI followed by incubation with 
R.TaqI enzyme; Lane 3: Labeling of R.XmnI-linearized pUC19 DNA with 8BAz (48) and 
M.TaqI; Lane 4: R.XmnI-linearized pUC19 DNA restricted with R.HindIII; Lane 5: Plasmid 
pUC19 DNA; Lane 6: DNA ladder 1 (80 ng). 
 
After linearization, pUC19 DNA was labeled with 8BAz (48) and M.TaqI. The ability of 
8BAz (48) to function as a cofactor for the DNA MTase M.TaqI was analyzed in a standard 
DNA protection assay. The M.TaqI alkylated 5’-TCGA-3’ recognition sequences can not be 
fragmented by the cognate restriction endonuclease R.TaqI during the restriction. The 
experiment result showed the complete labeling of four M.TaqI sites (Figure 14, lane 2). 
Additionally, different labeling conditions were tested in another experiment. Similarly, after 
the linearization with R.XmnI, the amount of M.TaqI enzyme was halved for labeling the 
linear DNA with 8BAz (48). The product was treated with Proteinase K enzyme before 
QIAprep Spin Miniprep Kit purification. The linearization assay as well as the  
restriction-modification assay of labeling experiment demonstrated similar results compared 
to the previous tests (Figure 15).  
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Figure 15: Agarose gel analysis of linearization and successive labeling of pUC19 DNA  
(1% agarose gel). 
A) Fragmentation of R.XmnI-linearized pUC19 DNA with R.HindIII. Lane 1: DNA ladder 1  
(50 ng); Lane 2: R.XmnI-linearized pUC19 DNA treated with R.HindIII; Lane 3: Plasmid 
pUC19 DNA (100 ng). 
B) The labeling reaction with 8BAz (48) and M.TaqI. Lane 1: DNA ladder 1 (100 ng);  
Lane 2-7: The kinetic progress of the labeling reaction after 0 h, 0.5 h, 1 h, 2 h, 3 h, 5 h;  
Lane 8: 5h labeling reaction plus Proteinase K treatment and incubation with R.TaqI;  
Lane 9: 5h labeling reaction plus Proteinase K treatment; Lane 10: The control labeling 
reaction without 8BAz (48) and incubation with R.TaqI; Lane 11: The control labeling reaction 
without 8BAz (48); Lane 12: The control labeling reaction without M.TaqI and incubation with 
R.TaqI; Lane 13: The control labeling reaction without M.TaqI; Lane 14: The control labeling 
reaction without 8BAz (48) and M.TaqI with R.TaqI incubation; Lane 15: The control labeling 
reaction without 8BAz (48) and M.TaqI. 
 
The labeled DNA was sent to Dr. Rudi Lurz at Max-Planck-Institute for Molecular Genetics 
in Berlin. The precision of the labeling method was proven by the electron microscopy 
analysis (Pljevaljcic et al., 2007).  
The pUC19 plasmid was linearized with the restriction endonuclease R.XmnI at position 
2294, which left all four recognition sequences for M.TaqI intact, and was then biotinylated 
with 8BAz (48) and M.TaqI. After DNA purification and addition of streptavidin, four extra 
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spots were observed on the DNA product by electron microscopy analysis (Figure 16A, top 
panel) which are attributed to streptavidin bound to the modified DNA. Without streptavidin 
the purified biotinylated DNA was mainly free of these spots (Figure 16A, lower panel). 
Analysis of 150 DNA molecules with added streptavidin demonstrated a clear preference for 
the expected positions at 2360, 400, 430 and 906 (Figure 16B). 
 
 
 
Figure 16: Electron microscopy of R.XmnI-linearized pUC19 plasmid biotinylated with 
aziridine cofactor 8BAz (48) by using M.TaqI and treated with streptavidin (adapted from 
Pljevaljcic et al., 2007). 
A) Single DNA strand with four streptavidin molecules bound to the biotinylated M.TaqI 
recognition sequences (arrows with position numbers). The lower panel shows an electron 
micrograph without added streptavidin as control.  
B) Frequency of spots observed over the entire DNA. 
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3.3.4 Synthesis of 6BAz, labeling of pBR322 with 6BAz and M.BseCI 
The synthesis of 6BAz (35) was performed according to the literature (Schmidt, 2004). 
Product was purified by RP-HPLC (Figure 17) and the isolated product was dried by 
lyophilization. Then the product was redissolved in DMSO. 
 
 
 
Figure 17: RP-HPLC analysis of the reaction progress for the synthesis of 6BAz (35) after  
1 h. 
 
Biotinylated aziridine cofactor 6BAz (35) was used to label pBR322 DNA with M.BseCI 
DNA MTase, which methylates the 3' adenine residue in the 5'-ATCGAT-3' sequence  
(one recognition sequence). After the labeling reaction, DNA was restricted with R.TaqI  
(six restriction sites) and treated with streptavidin. 35 contains the affinity tag biotin and due 
to the strong, non-covalent interaction between biotin and streptavidin, the labeled fragment 
show shift to the higher molecular weight. Furthermore, this shift was accompanied by the 
disappearance of the 368 bp fragment (Figure 18). 
These experiments were performed with Prof. Helm’s (University of Heidelberg) coworker 
Jakob Zipprich and after the experiments 35 was given to him for studies on RNA labeling. 
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Figure 18: Streptavidin shift assay of labeled pBR322 DNA with 6BAz (35) and M.BseCI  
(1% agarose gel). Lane 1: DNA ladder 1 (100 ng); Lane 2-3: Control experiment, labeling 
reaction without 35; Lane 4-5: Control experiment, labeling reaction without M.BseCI;  
Lane 6-13: Labeling reaction progress; 0 h, 0.5 h, 1 h, 3 h; Lane 14: DNA ladder 1 (66 ng). 
The presence of components is shown with (+) and absence with (-).  
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3.3.5 Labeling of duplex ODN with 6BAz and M.TaqI or M.HhaI 
For a collaboration project with Prof. Friedhoff (Justus-Liebig Universität Giessen) the 484 bp  
duplex ODNs were labeled. Duplex ODNs were labeled for functional studies of DNA 
mismatch repair. 
The duplex ODN was labeled with 6BAz (35) and M.TaqI (two recognition sequences, 4 mol 
eq. per DNA recognition sequence was used). The kinetic progress of the reaction showed the 
completion of the labeling after 5 h (Figure 19). Restriction analysis did not lead to 
fragmentation. The control experiments were also performed to confirm the result. They 
demonstrated the fragmentation (three bands) with R.TaqI enzyme (Figure 20). Positive 
control with AdoMet (1) showed no fragmentation. 
 
 
 
Figure 19: The labeling assay of 484 bp duplex ODN with 6BAz (35) and M.TaqI  
(1% agarose gel). Lane 1: DNA ladder 3 (5 µg); Lane 2: DNA ladder 1 (100 ng);  
Lane 3-8: Labeling reaction progress; 0 h, 0.5 h, 1 h, 2 h, 3.5 h, 5 h; Lane 9: Labeling 
reaction followed by QIAprep Spin Miniprep Kit purification and treatment with R.TaqI; Lane 
10: Labeling reaction followed by QIAprep Spin Miniprep Kit purification; Lane 11: DNA 
ladder 1 (50 ng). The presence of components is shown with (+) and absence with (-).  
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Figure 20: The control experiments for labeling assay of 484 bp duplex ODN with 6BAz (35) 
and M.TaqI (1% agarose gel). Lane 1: DNA ladder 3 (5 µg); Lane 2: DNA ladder 1 (100 ng); 
Lane 3: The control labeling reaction without 35 with R.TaqI treatment; Lane 4: The control 
labeling reaction without 35; Lane 5: The control labeling reaction without M.TaqI with R.TaqI 
treatment; Lane 6: The control labeling reaction without M.TaqI; Lane 7: The control labeling 
reaction without 35 and M.TaqI with R.TaqI treatment; Lane 8: The control labeling reaction 
without 35 and M.TaqI; Lane 9: The positive control labeling with AdoMet (1) and M.TaqI with 
R.TaqI treatment; Lane 10: The positive control labeling with AdoMet (1) and M.TaqI;  
Lane 11: DNA ladder 1 (50 ng). The labeling reactions were analyzed without purification. 
The presence of components is shown with (+) and absence with (-). 
 
Similar duplex ODN (484 bp, same sequence except the following; HO: Homoduplex with an 
extra GATC site, HE: Heteroduplex with an extra GATC site containing a G/T mismatch 
within an R.HindIII restriction site) was labeled with 6BAz (35) and M.HhaI. Labeling was 
followed by restriction analysis with R.HhaI (cuts 5’-GCG/C-3’, three restriction sequences). 
The labeled DNA was isolated by QIAprep Spin Miniprep Kit and analyzed by agarose gel 
electrophoresis. Complete protection was observed (Figure 21A). Furthermore, control 
experiments of HO and HE duplex ODNs with R.HhaI enzyme were conducted. Treatment of 
original duplex ODNs with R.HhaI showed fragmentation as expected (Figure 21B). 
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Figure 21: A) The labeling assay of 484 bp duplex ODN (HO and HE) with 6BAz (35) and 
M.HhaI. Lane 1: DNA ladder 1 (100 ng); Lane 2: Labeling reaction of HO duplex ODN and 
R.HhaI treatment; Lane 3: Labeling reaction of HO duplex ODN; Lane 4: Labeling reaction of 
HE duplex ODN and R.HhaI treatment; Lane 5: Labeling reaction of HE duplex ODN;  
Lane 6: DNA ladder 1 (50 ng); Lane 7: DNA ladder 3 (5 µg). All samples were purified by 
QIAprep Spin Miniprep Kit prior to analyses. The presence of components is shown with (+) 
and absence with (-).  
B) The control experiment for labeling the 484 bp duplex ODN (HO and HE). Lane 1: DNA 
ladder 1 (100 ng); Lane 2: HO duplex ODN with R.HhaI treatment; Lane 3: HO duplex ODN 
without R.HhaI treatment; Lane 4: HE duplex ODN with R.HhaI treatment; Lane 5: HE duplex 
ODN without R.HhaI treatment; Lane 6: DNA ladder 1 (50 ng); Lane 7: DNA ladder 3 (5 µg). 
The presence of components is shown with (+) and absence with (-). 
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4. Summary, Conclusions and Outlook 
4.1 Novel aziridine cofactor 6RBAz to detect DNA methylation  
Abnormalities in DNA methylation indicate cancer formation in mammalian cells and early 
detection is crucial for a successful treatment. Present detection methods are complicated and 
time-consuming therefore new, alternative technologies are required. A novel aziridine 
cofactor was designed and synthesized for DNA methylation detection. The DNA methylation 
detection was based on the Road Block concept (s. 1.5), which consists of the following steps:  
1. Labeling of unknown sample DNA by SMILing DNA using the novel cofactor and a 
suitable DNA MTase 
2. PCR amplification of the sample DNA and the labeled DNA 
3. Comparing the amplification results of the sample DNA vs. the labeled DNA by 
agarose gel electrophoresis analysis 
The Road Block approach required certain properties for the novel cofactor to block the 
polymerase enzyme efficiently during PCR and to produce amplification differences. The 
cofactor was designed to possess the following properties: 
 Rigid unit to block DNA polymerase 
 Overall polarity for biocompatible experiments 
 Recognition unit for MTase  
 Electrophilicity on recognition unit to facilitate the DNA base attack 
The synthesis of the rigid unit was executed by four different strategies. These strategies were 
performed to create conjugated phenyleneethynylenes (rigid unit) furnished with polar side 
chains. The strategies were designed to produce different length of rigid units (i.e. variable 
total conjugated phenylene ring number). Synthesized rigid units were conjugated with 
recognition unit 26 by peptide coupling. The synthesis of 26 is straightforward until the 
activation of 5’ hydroxyl group. The activation with mesylchloride should be performed at  
0 
o
C to avoid intramolecular side reaction. Moreover, after substitution of mesylate with 
aziridine, 26 should be handled carefully due to its stability problem. Thawing should be 
either avoided or thawed 26 should be completely consumed. Freshly prepared 26 should be 
preferred if possible. 
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The conclusions for rigid unit’s synthetic strategies are summarized below: 
1. Direct Sonogashira coupling: This strategy produced the highest yields out of four. 
The resulting 19 contains three conjugated phenylene rings (3.1.3.2). Counter ions of 
19 were exchanged by cation exchange chromatography to enable solubility in DMA. 
Characterization of 19 was achieved by NMR, IR, UV, fluorescence spectroscopy and 
also by ESI-MS (negative ion mode) measured in NaOH (0.1 M). 19 was successfully 
coupled with 26 to produce 6RBAz (29, Scheme 25). The peptide coupling reaction 
was carried out with the coupling reagent TBTU. The selection of DIPEA as a base 
and DMA as a cosolvent was found to be important. The molecular ratio of 1:1 
between 19 and 26 worked well. Furthermore, during the peptide coupling reaction the 
volume ratio of 26 in elution buffer (contains aqueous TEAHCO3 and acetonitrile) to 
DMA was set to be 1:1 which was concluded to be the optimal condition. Instability of 
26 (see 3.1.4 for comprehensive explanation) is a critical element to consider for the 
success of the coupling reaction. When freshly prepared 26 was used, reaction resulted 
in better yields. Characterization of 6RBAz (29) was achieved by LC-MS analysis 
(positive ion mode). Finally, 6RBAz (29) was lyophilized and redissolved in DMSO 
for DNA labeling studies. 
2. Stoichiometric Sonogashira coupling: This strategy produced a rigid unit with five 
phenylene units (3.1.3.3). The Sonogashira coupling reaction worked well; however, 
the purification by RP-HPLC resulted in low yields and took immense amount of time. 
The characterization of 32 was done by NMR. The peptide coupling of 32 with 26 
produced new peaks with reasonable UV character and retention time however, 
isolated product peaks could not be characterized.  
3. Controlled extension: This strategy presents a general way to extend the length of the 
rigid unit in a step-wise fashion (3.1.3.4). The difficulties were encountered mainly 
during the purification and characterization step of the unsymmetrical building block. 
4. Extension through polymerization: This strategy (3.1.3.5) was based on altering the 
polymerization conditions to obtain lower molecular weights (repeating units < 5). 
Desired lower molecular weight rigid unit 34 was obtained and characterized 
according to NMR end group analysis. The yield was relatively low and the end 
groups could not be functionalized by carboxylic acid groups. For future studies, the 
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purification and cation exchange of 34 can be performed in a same way as 19. Then 
the end group functionalization can be tried.  
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Scheme 25: Overall synthesis of 6RBAz (29). R represents sodium or triethylammonium 
propane-1-sulfonate. 
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For future DNA labeling studies with 6RBAz (29) M.TaqI should be initially tried. M.TaqI 
accepts a large number of aziridine cofactors to label DNA (Schmidt, 2004). Linearized 
pBR322 or pUC19 can be selected as initial substrate. After observing the successful labeling 
of DNA by SMILing DNA with 6RBAz (29) and M.TaqI, labeled DNA can be used for 
testing Road Block approach. Similar experimental setup for the PCR amplification could be 
used as described in 3.3.2. Special attention should be given to the quantification of labeled 
vs. non-labeled DNA before PCR amplification for a quantitative comparison. Quantification 
of the results can be done by agarose gel electrophoresis. Alternatively, real-time PCR can be 
considered for quantification. Furthermore, sequencing can be performed to obtain additional 
information about stop sites.  
 
4.2 Synthesis of 6TAMRAAz cofactor for DNA labeling 
Synthesis and optimal purification system of the novel aziridine cofactor 6TAMRAAz (31) 
was achieved (3.2). The novel compound can be used for further applications of SMILing 
DNA. 
 
4.3 SMILing DNA applications  
SMILing DNA offers a delicate method to label DNA with fluorophores. It is well suited for 
laser assisted cell poration (photoporation) application to prove the viability of the method. 
For the collaboration project with “Fraunhofer-Institut für Lasertechnik”, pAcGFP1-N2 DNA 
was labeled with 6TexAz (47) (see 3.3.1).  
 
SMILing DNA matches well for quantitative labeling of DNA with nanometer precision. For 
the collaboration project with Dr. Rudi Lurz at Max Planck Institute for Molecular Genetics in 
Berlin, R.XmnI linearized pUC 19 DNA was labeled with M.TaqI and 8BAz (48) (see 3.3.3). 
The labeling performance was checked by restriction analysis with R.TaqI. Finally, labeled 
DNA was treated with streptavidin and analyzed by electron microscopy (Pljevaljcic et al., 
2007). 
 
In collaboration with Prof. Helm from the University of Heidelberg, his coworker was trained 
on SMILing DNA method. pBR322 DNA was labeled with 6BAz (35) and M.BseCI  
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(see 3.3.4). Labeled DNA was further treated with streptavidin to produce a streptavidin shift. 
Prof. Helm and his coworker tested 6BAz (35) for RNA labeling. 
 
For the collaboration project with Prof. Friedhoff, Justus-Liebig Universität Gießen, the  
484 bp duplex ODNs were labeled (3.3.5). The duplex ODNs were labeled with 6BAz (35) 
and M.TaqI. Restriction analysis was performed with R.TaqI. Second set of duplex ODNs 
containing homo and heteroduplex sites were labeled with 6BAz (35) and M.HhaI. Restriction 
analysis was performed with R.HhaI. All labeled duplex ODNs were delivered to Gießen for 
functional studies on DNA mismatch repair. 
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5. Materials and Methods 
5.1  Chemicals 
The chemicals were purchased from the following companies in highest purity available. 
Company Chemical 
Acros Organics 6-Chloroadenosine 
 
Boron tribromide  
CDCl3 
Dimethylformamide (extra dry) 
Ether (extra dry) 
Tetrahydrofurane (extra dry) 
Aldrich 1,3-Propanesultone  
1,4-Bis[(trimethylsilyl)ethynyl]benzene 
1,4-Dimethoxybenzene 
4-Iodobenzoic acid 
Dichlorobis(triphenylphosphine)palladium(II) 
Dimethylacetamide (DMA) 
Dowex 50 WX8-400 
Ethinyltrimethylsilane  
Iodinemonochloride 
N- Hydroxysuccinimide 
Triethylamine 
Tetrakis(triphenylphosphine)palladium(0) 
Cambridge Isotope Laboratories [D6] DMSO 
Deutero GmbH D2O 
Fisher Scientific Acetonitrile (HPLC gradient grade) 
 Tetrahydrofurane (HPLC gradient grade) 
Fluka 1,4-Diaminobutane 
 
2,2-Dimethoxypropane 
Calcium chloride 
Sodium hydroxide 
N-Ethyldiisopropylamine (EDIA) 
 
Materials and Methods 
 
72 
 
Company Chemical 
Fluka 
O-(Benzotriazol-1-yl)-N,N,N',N'-tetramethyl-
uronium tetrafluoroborate (TBTU) 
 Trifluoroethyl acetate 
 Toluolsulfonic acid monohydrate 
Julius Hoesch Isopropanol 
 Petroleum ether 
Merck 4-(Dimethylamino)-pyridine (DMAP) 
 Dichloromethane 
 Diisopropylamine 
 Dimethylsulfoxide 
 Sodium chloride 
 Magnesium sulfate (water-free) 
 Methansulfonylchloride 
 Sodium hydrogen carbonate 
KMF Diethylether 
 Ethylacetate 
 Potassium carbonate 
 Potassium hydroxide 
 Toluol 
Westfalen Methanol 
VWR Formic acid 
Riedel de Haen Copper(I) iodide 
J.T.Baker Acetone 
Promochem Argon 
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5.2 General instrumentation 
Water (HPLC grade) was purified with an ELIX 3 Water System and a passage through 
Milli-Q Academic water-purification system from Millipore (Eschborn). 
Synthesized compounds were lyophilized in a Speed Vac Plus SC 110A combined with a 
Savant RVT 100 Vapor Trap. 
Centrifugation was carried out using a table Centrifuge 5415 C from Eppendorf (Cologne, 
Germany). 
Measurements of pH values were performed using a pH-meter 761 from Calimatic Knick 
(Berlin, Germany). 
 
 
5.3 Spectroscopy and spectrometry 
5.3.1 NMR spectroscopy 
1
H-NMR spectra were measured using an Inova 400 (400 MHz, Varian) or a Mercury 300 
spectrometer (300 MHz, Varian). 
13
C-NMR spectra were recorded with an Inova 400 
(100 MHz, Varian) or a Mercury 300 (75 MHz, Varian). 
19
F-NMR spectra were measured 
with the same instruments. All measurements were performed at RT. 
The chemical shifts δH (
1
H) and δC (
13
C) are reported in ppm and were referenced to TMS  
(δ = 0). The signal of the used solvents is used for calibration (Gottlieb et al., 1997). The 
following abbreviations are used for the signal multiplicities: s (singlet), d (doublet), dd 
(doublet of doublets), t (triplet), q (quartet), m (multiplet), br. (broad); the coupling constants 
J are given in Hertz (Hz).  
 
 
5.3.2 Mass spectroscopy  
Mass spectra were taken with the following instruments: Finnigan SSQ 7000 for EI, 
ThermoFinnigan LCQ Deca XP plus for ESI and regular reversed-phase LC/MS and 
ThermoFisher Scientific LTQ-Orbitrap XL for high resolution reversed-phase LC/MS. 
Regular reversed-phase LC/MS and high resolution reversed-phase LC/MS were done with a 
C18 Hypersil GOLD column (100 x 2.1 mm, 3 µm) from Thermo Scientific using a flow rate 
of 0.2 ml/min. 
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5.3.3 UV-Vis absorption spectroscopy 
UV-Vis absorption spectroscopy measurements were carried out with a UV-Visible- 
Spectrophotometer Cary 3E (Varian, Darmstadt). 
 
 
5.3.4 Fluorescence spectroscopy 
Fluorescence measurements were performed with a CARY Eclipse Fluorescence 
Spectrophotometer (Varian, Darmstadt) equipped with a thermo-controlled cell holder. The 
excitation and the emission slit width were 2.5 nm. 
 
 
5.3.5 Infrared spectroscopy  
Infrared spectroscopy measurements were conducted with a PerkinElmer Spektrum 100 
instrument. The major bands are reported in cm
-1
. 
 
 
5.3.6 Elemental analysis 
Elemental analyses were performed with a Heraeus CHN-Rapid instrument. 
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5.4 HPLC 
Reversed-phase HPLC (high performance liquid chromatography) was carried out with two 
Waters Breeze Systems consisting of a Waters 1525 binary pump system and a Waters 2487 
Dual λ absorbance detector. The systems were controlled by the Breeze Software  
(Waters, Eschborn) running on Windows XP. Chromatography was performed at RT. The two 
systems were identical except their sample loop size. For simplicity the first system with a  
1 ml sample loop was named as HPLC1 and the second system with a 5 ml sample loop was 
named as HPLC2. 
Analytical studies of the purified compounds as well as examination of the reaction progress 
were done by reversed-phase HPLC with a NC Prontosil C18 column (250 x 4.6 mm, 5 µm, 
120 Å) from Bischoff using a flow rate of 1 ml/min. Purification of amounts up to 10 mg was 
done by reversed-phase HPLC with SNC Prontosil C18 column (250 x 8 mm, 5 µm, 120 Å) 
from Bischoff using a flow rate of 3 ml/min. 
 
System  Buffer A    Buffer B 
  
 1   10 mM TEAHCO3 pH 8.5  Buffer A + 70% vol. CH3CN 
 2   0.01% TFA pH 2.7   Buffer A + 70% vol. CH3CN 
 3   10 mM TEAHCO3 pH 8.5  Buffer A + 52% vol. THF 
 
Gradient  Run 
 
Gradient 1 0 – 5 min (10% Buffer B), 5 – 8 min (10 – 40% Buffer B), 8 – 30 min 
(40 – 80% Buffer B), 30 – 32 min (80 – 100% Buffer B),  
32 – 34 min (100% Buffer B), 34 – 35 min (100 – 10% Buffer B). 
Gradient 2 0 – 5 min (10% Buffer B), 5 – 10 min (10 – 70% Buffer B),  
10 – 20 min (70% Buffer B), 20 – 25 min (70 – 100% Buffer B),  
25 – 35 min (100% Buffer B), 35 – 37 min (100 – 10% Buffer B). 
Gradient 3 0 – 5 min (30% Buffer B), 5 – 15 min (30 – 100% Buffer B),  
15 – 19 min (100% Buffer B), 19 – 21 min (100 – 30% Buffer B). 
Gradient 4 0 – 5 min (10% Buffer B), 5 – 25 min (10 – 100% Buffer B),  
25 – 30 min (100% Buffer B), 30 – 32 min (100 – 10% Buffer B). 
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Gradient 5 0 – 5 min (30% Buffer B), 5 – 15 min (30 – 50% Buffer B), 15 – 19 min 
(50 – 100% Buffer B), 19 – 21 min (100% Buffer B), 21 – 22 min  
(100 – 30% Buffer B). 
Gradient 6 0 – 5 min (15% Buffer B), 5 – 16 min (15 – 30% Buffer B), 16 – 25 min 
(30 – 65% Buffer B), 25 – 27 min (65 – 100% Buffer B), 27 – 29 min 
(100% Buffer B), 29 – 31 min (100 – 15% Buffer B). 
Gradient 7 20% Buffer B isocratic. 
Gradient 8 0 – 5 min (30% Buffer B), 5 – 20 min (30 – 100% Buffer B),  
20 – 24 min (100% Buffer B), 24 – 26 min (100 – 70% Buffer B). 
Gradient 9 0 – 5 min (20% Buffer B), 5 – 10 min (20 – 45% Buffer B), 10 – 20 min 
(50% Buffer B), 20 – 25 min (100% Buffer B), 25 – 30 min  
(100 – 20% Buffer B), 30 – 31 (20% Buffer B). 
 
 
5.5 Chromatography 
For TLC silica gel 60 F254 (d = 0.25 mm) on glass plates from Merck and silica gel 60 F254 
(d = 0.2 mm) on aluminum foil from Fluka were used. Compounds were either detected by 
irradiation with UV light (254 nm and 365 nm) or by staining with one of the following 
solutions and drying with a heat gun. 
Solution for the detection of sugar derivatives: Ammoniummolybdate tetrahydrate 
[(NH4)6Mo7O24•4H2O] (2.5 g), cer (IV) sulfate tetrahydrate (1 g) and concentrated sulfuric 
acid (10 ml) were diluted with water (1:10). 
Solution for the detection of primary amines (ninhydrin solution): Ninhydrin (0.3 g) was 
dissolved in ethanol (100 ml) and it was mixed with acetic acid (3 ml). 
Column chromatographic separation of compounds was achieved by using 50 – 100 times the 
sample amount of silica gel 60 (230 – 400 mesh, particle size 0.040 – 0.063 mm) from Merck. 
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5.6 Syntheses 
All reactions were performed under argon atmosphere unless otherwise stated. For 
Sonogashira coupling reactions Schlenk flasks were used as reaction vessel. Prior to use all 
glassware and the stir bar were kept in an oven at 100 °C for 15 min. After this, the reaction 
apparatus was flushed with argon for 15 min before adding the reactants. The catalysts were 
always added last after stirring the reactants in solvent for at least 15 min under intensive 
argon flush. 
 
5.6.1 1,4-Diiodo-2,5-dimethoxybenzene (10) 
 
 
 
ICl (7.24 ml, 144 mmol) was added dropwise (ICl was solid at RT so it was warmed gently 
before use) into methanol (50 ml) under argon conditions at around 0 °C (caution was taken as 
this reaction is highly exothermic). Subsequently 1,4-dimethoxybenzene (9) (5.0 g, 36 mmol) 
was added to the resulting solution. The ice-bath was removed and the reaction was refluxed 
at 80 °C for 4 h. After cooling to RT, a precipitate formed which was collected by filtration. 
The precipitate was washed with cold methanol and dried under high vacuum to yield 10 
(9.74 g, 69%) as a white powder. 
 
Rf = 0.5 (silica gel on aluminum foil, hexane/ethylacetate; 10:1). 
 
1
H-NMR: (300 MHz, CDCl3): δ = 3.82 (s, 6H), 7.18 (s, 2H). 
 
13
C-NMR: (100 MHz, CDCl3): δ = 57.28 (CH3), 85.51 (aromatic, RCI), 121.59  
(aromatic CH), 153.25 (aromatic, RCOMe). 
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IR (KBr): 1479, 1209, 1058 cm
-1
. 
 
MS (EI): m/z (%): 390.9 (20.8) [M + 1]
+
, 389.8 (100) [M]
+
, 374.9 (75.8) [M – CH3]
+
, 248.0 
(17.3) [M – CH3 – I]
+
, 233.0 (23.5) [M – 2CH3 – I]
+
. 
 
CHN-Elemental-Analysis:  Analysis calc: C 24.64; H 2.070 
    Analysis found: C 24.69; H 1.995 
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5.6.2 2,5-Diiodobenzene-1,4-diol (11) 
 
 
 
A round bottom flask (250 ml) was cooled to -69 
o
C with a dry ice bath. In this flask 10  
(4.00 g, 10.3 mmol) was dissolved in DCM (80 ml). BBr3 (4.20 ml, 43.6 mmol) was added 
dropwise to this solution via a syringe. The reaction was left stirring overnight. The reaction 
mixture was poured into an ice-water mixture (500 ml). The precipitate was filtrated off and 
washed with water. The resulting white product was dried under reduced pressure to yield 11 
(3.26 g, 87.5%). 
 
Rf = 0.06 (silica gel on aluminum foil, hexane/ethylacetate; 10:1). 
 
1
H-NMR: (400 MHz, DMSO-d6): δ = 7.14 (s, 2H, aromatic), 9.80 (s, 2H). 
 
13
C-NMR: (75 MHz, DMSO-d6): δ = 84.77 (aromatic RCI), 124.01 (aromatic CH), 150.82 
(aromatic, RCOH). 
 
IR (KBr): 3247, 1400, 1185, 1043 cm
-1
. 
 
MS (EI): m/z (%): 362.9 (19.0) [M + 1]
+
, 361.8 (100) [M]
+
, 235.0 (14.0) [M – I]+. 
 
CHN-Elemental-Analysis:  Analysis calc: C 19.91; H 1.110 
    Analysis found: C 19.59; H 1.196 
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5.6.3 1,4-Diiodo-2,5-di(propyloxysodiumsulfonate)benzene (12)  
 
 
 
In a dry round bottom flask 11 (2.0 g, 5.5 mmol) and NaOH (0.662 g, 16.6 mmol) were 
dissolved in water (80 ml). In another flask 1,3-propanesultone (1.68 g, 13.8 mmol) was 
dissolved in dioxane (16 ml) and added to the first mixture under argon atmosphere. The 
purple reaction mixture was stirred under argon atmosphere overnight. The next day the 
resulting reaction mixture was heated at 80 
o
C for 15 min. After cooling the reaction mixture 
to RT the solvent was removed by rotavapor. The product was dissolved in a small amount of 
water and precipitated by adding to acetone (1 l). The resulting suspension was cooled to  
-80 
o
C for 10 min. Then it was filtrated and the product was dried under reduced pressure. 
Product 12 was obtained as a white powder (3.2 g, 89.2%).  
 
1
H-NMR: (400 MHz, DMSO-d6): δ = 1.96 – 2.04 (m, 4H, OCH2CH2CH2SO3), 2.63  
(t, 
3
J = 7.42 Hz, 4H, OCH2CH2CH2SO3), 4.05 (t, 
3
J = 6.3 Hz, 4H, OCH2CH2CH2SO3), 7.30  
(s, 2H, aromatic-CH). 
 
13
C-NMR: (100 MHz, DMSO-d6): δ = 25.86 (OCH2CH2CH2SO3), 48.56 
(OCH2CH2CH2SO3), 69.37 (OCH2CH2CH2SO3), 87.38 (aromatic, RCI), 122.78  
(aromatic CH), 152.60 (aromatic RCO). 
 
IR (KBr): 1204, 1155, 1052 cm
-1
. 
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ESI-MS: m/z (%): 626.6 (21.1) [M – Na]-, 301.8 (19.5) [M – 2Na]-2, 240.9 (100)  
[M – 2Na – I]-2.  
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5.6.4 4-[(Trimethylsilyl)ethynyl]benzoic acid (16) 
 
 
 
A schlenk flask with a stir bar inside was heated in the oven for 15 min. Then, the flask was 
allowed to cool down and it was flushed with argon for another 15 min. To this flask 15  
(12.6 g, 50.9 mmol), dry THF (75 ml), TEA (28.40 ml, 203.6 mmol) and 
ethynyltrimethylsilane (14.4 ml, 50.9 mmol) were added. After stirring for 15 min, copper(I) 
iodide (291 mg, 1.53 mmol) and tetrakis(triphenylphosphine)palladium(0) (1.78 g,  
1.54 mmol) were added to stir at 50 
o
C for 7 h. The solvent was removed by rotavapor. The 
resulting orange-brown product was dissolved in water and treated with acetic acid to adjust 
the pH to 4.5. This suspension was supplemented with a brine solution and it was extracted 
several times with DCM until no significant amount of product was observed in the water 
phase by TLC. The organic phase was collected, dried over MgSO4 and the solvent was 
removed by rotavapor. The resulting brown solid product was purified by column 
chromatography (silica gel, 300 g, elution with CH2Cl2/MeOH, 99:1) to obtain 16 (8.00 g, 
72.4%). 
 
Rf = 0.31 (DCM/MeOH/CH3COOH; 89:10:1). 
 
1
H-NMR: (400 MHz, CDCl3): δ = 0.32 (s, 9H, SiC3H9), 7.60 (d, 
3
J = 8.25 Hz, 2H, 
COOHCCHCHCR,), 8.10 (d, 
3
J = 8.24 Hz, 2H, COOHCCHCHCR,). 
 
13
C-NMR: (100 MHz, CDCl3): δ = 0.00 (SiCH3), 98.41 (RC≡CSiC3H9), 103.95 
(RC≡CSiC3H9), 128.99 (COOHCCHCHCR), 129.99 (COOHCCHCHCR), 131.95 
(COOHCCHCHCR), 171.72 (COOHCCHCHCR). 
 
IR (KBr): 1681, 1423, 835 cm
-1
. 
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MS (EI): m/z (%): 219.1 (10.4) [M + 1]
+
, 218.1 (48.6) [M]
+
, 203.1 (100) [M – CH3]
+
, 204.1 
(46.7) [M – CH3 + 1]
+
. 
 
CHN-Elemental-Analysis: Analysis calc: C 66.02; H 6.460 
    Analysis found: C 65.76; H 6.421  
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5.6.5 4-Ethynylbenzoic acid (17) 
 
 
 
16 (3.50 g, 16.0 mmol) was dissolved in methanol (10 ml). Upon addition of K2CO3  
(8.90 g, 64.4 mmol) solution turned turbid. After the addition of water (10 ml), turbidity 
disappeared accompanied by gas generation. The reaction mixture was left stirring overnight. 
For the work-up first the remaining methanol was removed by rotavapor. Then the pH of the 
water phase was adjusted to 4.5-5 and the solution was extracted several times with DCM and 
NaCl until no significant amount of product was observed in the water phase by TLC. The 
organic phase was collected, dried over MgSO4 and the solvent was removed by rotavapor. 
The product was dried under reduced pressure to yield 17 (2.10 g, 89.6%) as a brown solid.  
 
Rf = 0.55 (DCM/MeOH/CH3COOH; 89:10:1). 
 
1
H-NMR: (300 MHz, DMSO-d6): δ = 4.61 (s, 1H, acetylene), 7.68 (d, 3J = 8.41 Hz, 2H, 
COOHCCHCHCR), 8.03 (d, 
3
J = 8.16 Hz, 2H, COOHCCHCHCR), 13.20 (s, br., 1H, 
COOH). 
 
13
C-NMR: (75 MHz, DMSO-d6): δ = 83.19 (RC≡CH), 83.95 (RC≡CH), 126.43 
(COOHCCHCHCR), 129.91 (COOHCCHCHCR), 131.40 (COOHCCHCHCR), 132.32 
(COOHCCHCHCR), 167.10 (COOHCCHCHCR). 
 
IR (KBr): 3270, 1683, 1427, 1322, 1285 cm
-1
. 
 
MS (EI): m/z (%): 146.1 (100) [M]
+
, 130.1 (9.68) [M – O]+, 102.1 (6.03) [M – CO2]
 +
. 
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CHN-Elemental-Analysis:  Analysis calc: C 73.97; H 4.140 
    Analysis found: C 72.37; H 4.368 
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5.6.6 Disodium 3,3'-[(2,5-bis((4-carboxyphenyl)ethynyl)-1,4 - phenylene)] - bis - (oxy) 
 dipropane-1-sulfonate (18) 
 
 
 
A schlenk flask with a stir bar inside was heated in the oven for 15 min. Then, the flask was 
allowed to cool down and it was flushed with argon for another 15 min. 17 (900 mg,  
6.16 mmol) and 12 (800 mg, 1.23 mmol) were dissolved in DMF (50 ml) and water (5 ml) 
along with TEA (0.89 ml, 6.38 mmol). After stirring for 15 min, copper(I) iodide (11.7 mg,  
61.5 µmol) and tetrakis(triphenylphosphine)palladium(0) (142 mg, 123 µmol) were added. 
The reaction mixture was stirred at 50 
o
C for 4 h and then overnight at RT under argon 
atmosphere. The resulting solution exhibited an intense blue fluorescence when illuminated 
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with a near-UV lamp. The reaction mixture was added to a methanol/acetone/diethylether 
mixture (1:4:5, 1 l) to precipitate. Solution was carefully removed by pipette as much as 
possible. The rest of the suspension was centrifuged to separate the solid phase. After 
decantation the solid was dried under reduced pressure and remaining solvents were 
coevaporated with methanol to obtain product 18 (770 mg, 91.2%). 
 
1
H-NMR: (400 MHz, D2O): δ = 2.13 (s, br., 4H, OCH2CH2CH2SO3), 3.04 – 3.10 (m, 4H, 
OCH2CH2CH2SO3), 4.07 (s, br., 4H, OCH2CH2CH2SO3), 6.98 (s, 2H, aromatic-CH), 7.40  
(s, 4H, COOHCCHCHCR), 7.64 (s, 4H, COOHCCHCHCR). 
 
IR (KBr): 3421, 1593, 1380, 1186, 1043 cm
-1
. 
 
ESI-MS: m/z (%): 663.1 (26) [M – Na]-, 641.1 (23) [M – 2xNa + H]-, 198.0 (100)  
[M – 2H – 2xCH2CH2CH2SO3]
-2
. 
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5.6.7 Di(triethylammonium)3,3'-[(2,5-bis((4-carboxyphenyl)ethynyl)-1,4 - phenylene)] - 
 bis - (oxy) dipropane-1-sulfonate (19) 
 
 
 
Cation exchange Dowex
®
 (10 g, composed of styrene-divinylbenzene functionalized with 
sulfonic acid group) was dissolved in TEAHCO3 buffer (1 M) until the end of gas generation 
observed. This resin was used as a column material for the cation exchange chromatography. 
18 (350 mg, 0.510 mmol) was dissolved in few milliliters of TEAHCO3 buffer (0.1 M) and 
loaded on the cation exchange column. Elution of 18 from the column was monitored by 
excitation of its fluorescence with a near-UV lamp. The collected fractions were dried under 
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reduced pressure using first the rotavapor and then high vacuum pump to obtain 19  
(344.8 mg, 80%). 
 
1
H-NMR: (400 MHz, DMSO-d6): δ = 1.18 (t, 3J = 7.14 Hz, 18H, triethylammonium-CH3), 
2.12 (t, 4H, 4H, OCH2CH2CH2SO3), 2.77 (t, 
3
J = 6.86 Hz, 4H, OCH2CH2CH2SO3,), 3.08  
(q, 
3
J = 6.87 Hz, 12H, triethylammonium-CH2), 4.21 (t, 
3
J = 5.49 Hz, 4H, OCH2CH2CH2SO3), 
7.24 (s, 2H, aromatic-CH), 7.71 (d, 
3
J = 7.69 Hz, 4H, COOHCCHCHCR), 8.00 (d, 4H, 
COOHCCHCHCR), 9.72 (s, br., 2H, COOH). 
 
13
C-NMR: (100 MHz, DMSO-d6): δ = 9.11 (triethylammonium-CH3), 25.99 
(OCH2CH2CH2SO3), 46.24 (triethylammonium-CH2), 48.48 (OCH2CH2CH2SO3), 68.57 
(OCH2CH2CH2SO3), 89.13 (COOHC6H4C≡CR), 94.47 (COOHC6H4C≡CR), 113.62 
(aromatic, COOHC6H4C≡CCR), 117.14 (aromatic, COOHC6H4C≡CCHR), 127.15  
(COOHCCHCHCR), 130.10 (aromatic, COOHCCHCHCR), 131.89 (aromatic, 
COOHCCHCHCR), 153.56 (aromatic, COCH2CH2CH2SO3). 
 
IR (KBr): 3439, 1598, 1374, 1214, 1150, 1025 cm
-1
. 
 
ESI-MS: m/z (%): 741.75 (20) [M – Et3NH]
-
, 641.16 (100) [M – 2x Et3NH + H]
-
, 320.16 (25) 
[M – 2x Et3NH]
-2
, 198.03 (70) [M – 2H – 2xCH2CH2CH2SO3]
-2
. 
 
CHN-Elemental-Analysis:  Analysis calc: C 59.70; H 6.68; N 3.320 
    Analysis found: C 58.31; H 7.606; N 4.047 
 
UV spectrum: λmax = 318 nm, λmax local = 384 nm 
 
Fluorescence spectrum: λex = 384 nm, λem = 455 nm  
 
Rt (system 1, gradient 3, HPLC2) = 6 min. 
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5.6.8 6-Chloro-2´,3´-O-isopropylideneadenosine (21) 
 
 
 
20 (1.75 g, 6.10 mmol) was partly dissolved in dry acetone (36 ml) placed in a dry, argon 
flushed round bottom flask. p-Toluenesulfonic acid monohydrate (1.1 g, 5.5 mmol) and  
2,2-dimethoxypropane (2.99 ml, 24.4 mmol) were added to this solution to stir at RT for 2 h. 
About 30 min later the reaction mixture was completely soluble and in orange-brown color. 
After 2 h TLC showed incomplete reaction therefore 2 more equivalents of  
2,2-dimethoxypropane (1.49 ml, 12.2 mmol) were added to the resulting solution to stir at RT 
overnight. The next day reaction was quenched with NaHCO3 solution (73 ml, 0.5 M). The 
acetone was removed by rotavapor and the water phase was extracted with chloroform  
(3 x 55 ml). Yellow organic layers were collected and dried over MgSO4. The solvent was 
removed by rotavapor and the product was dried under reduced pressure to obtain 21 (1.87 g, 
94%) as a white solid.  
 
Rf = 0.63 (DCM/MeOH; 90:10). 
 
1
H-NMR: (300 MHz, CDCl3): δ = 1.32 (s, 3H, isopropylidene-CH3a), 1.58  
(s, 3H, isopropylidene-CH3b), 3.76 (dd, 
3
J = 2.22 Hz, 
3
J = 12.37 Hz, 2H, H5´), 3.91  
(dd, 
3
J = 1.98 Hz, 
3
J = 12.37 Hz, 1H, H4´), 5.05 (dd, 
3
J = 1.48 Hz, 
3
J = 5.93 Hz, 1H, H3´), 
5.10 – 5.18 (m, 1H, H2´), 5.95 (d, 3J = 4.45 Hz, 1H, H1´), 8.25 (s, 1H, H8), 8.69 (s, 1H, H2). 
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13
C-NMR: (75 MHz, CDCl3): δ = 25.18 (isopropylidene-CH3a), 27.48 (isopropylidene-
CH3b), 63.11 (C5`), 81.50 (C3`), 83.45 (C2`), 86.45 (C4`), 93.84 (C1`), 114.42 
(isopropylidene-C(CH3)2), 133.05 (C5), 144.76 (C8), 150.50 (C2), 151.71 (C6), 151.92 (C4). 
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5.6.9 N6-(4''-Aminobutyl)-2',3'-O-isopropylideneadenosine (22) 
 
 
 
1,4-Diaminobutane (1.70 g, 19.6 mmol) and triethylamine (2.60 ml, 19.6 mmol) were 
dissolved in ethanol (10 ml). 21 (1.87 g, 5.7 mmol) was dissolved in ethanol (100 ml) and 
added dropwise to stirring solution. Then, the reaction mixture was heated to 64 
o
C and the 
reaction progress was monitored by TLC. Upon completion of the reaction, the solvent was 
removed by using first a rotavapor and then a high vacuum pump. The product 22  
(3.16 g, >100%) was used in the next step without any further purification. 
 
Rf = 0.0 (DCM/MeOH; 93:7). 
 
1
H-NMR: (300 MHz, DMSO-d6): δ = 1.33 (s, 3H, isopropylidene-CH3a), 1.55 (s, 3H,  
isopropylidene-CH3b), 1.59 – 1.64 (m, 4H, H2``, H3``), 2.49 – 2.58 (m, 2H, H4``), 3.50 – 3.58 
(m, 4H, H1``, H5`), 4.20 – 4.27 (m, 1H, H4`), 4.99 (dd, 3J = 2.48 Hz, 3J = 5.94 Hz, 1H, H3´), 
5.35 (dd, 
3
J = 2.96 Hz; 
3
J = 5.93 Hz, 1H, H2´), 6.16 (d, 
3
J = 2.96 Hz, 1H, H1´), 8.23  
(s, 1H, H8), 8.36 (s, 1H, H2). 
 
13
C-NMR: (75 MHz, DMSO-d6): δ = 25.62 (isopropylidene-CH3a), 27.50 (isopropylidene-
CH3b), 61.98 (C5`), 81.86 (C4`), 83.76 (C3`), 86.89 (C2`), 90.09 (C1`), 113.44 
(isopropylidene-C(CH3)2), 139.81 (C8), 153.07 (C2), 155.12 (C6). 
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5.6.10 N6-(4''-(Trifluoracetamido)butyl)-2',3'-O-isopropylideneadenosine (23) 
 
 
 
22 (3.08 g, 8.14 mmol) was dissolved in methanol (110 ml) and TEA (2.50 ml, 16.8 mmol). 
Trifluoroethyl acetate (5.0 ml, 42 mmol) was added to the reaction mixture to stir at RT 
overnight. The product was purified by column chromatography (elution with CH2Cl2/MeOH, 
98:2) and dried under reduced pressure to give 23 (3.47 g, 90%). 
 
Rf = 0.14 (DCM/MeOH; 95:5). 
 
1
H-NMR: (400 MHz, DMSO-d6): δ =1.34 (s, 3H, isopropylidene-CH3a), 1.56 (s, 3H, 
isopropylidene-CH3b), 1.57 – 1.63 (m, 4H, H2``, H3``), 3.16 – 3.24 (m, 2H, H4``),  
3.44 – 3.62 (m, 4H, H1``, H5`), 4.23 (m, 1H, H4`), 4.99 (dd, 3J = 2.47 Hz, 3J = 6.32 Hz, 1H, 
H3´), 5.26 (t, 
3
J = 5.49 Hz, 1H, 5’-OH), 5.35 (dd, 3J = 3.03 Hz, 3J = 6.05 Hz, 1H, H2’), 6.14 
(d, 
3
J = 3.02 Hz, H1’), 7.93 (s, br., 1H, 6-NH), 8.24 (s, 1H, H8), 8.36 (s, 1H, H2), 9.42  
(t, 
3
J = 5.49 Hz, 1H, amide). 
 
13
C-NMR: (100 MHz, DMSO-d6): δ = 25.72 (isopropylidene-CH3a), 26.08 (C3’’), 26.29 
(C2’’), 27.61 (isopropylidene-CH3b), 39.26 (C4’’), 39.40 (C1’’), 62.10 (C5’), 81.84 (C3’), 
83.74 (C2’), 86.86 (C4’), 90.14 (C1’), 113.45 (CF3), 119.90 (C5), 139.83 (C8), 152.97 (C2), 
154.99 (C4), 156.69 (C6). 
 
19
F-NMR: (376 MHz, DMSO-d6): δ = -74.44 (CF3).  
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5.6.11 N6-(4''-(Trifluoracetamido)butyl)-2',3'-O-(isopropylidene)-5'-O-mesyladenosine 
 (24) 
 
 
 
23 (1.28 g, 2.69 mmol) was dissolved in DCM (90 ml), TEA (9.37 ml, 67.3 mmol) and 
DMAP (329 mg, 2.69 mmol) at 0 
o
C. Mesylchloride (2.10 ml, 26.9 mmol) was added 
dropwise and the clear solution turned light-yellow upon addition. After stirring the reaction 
mixture for 36 min, the reaction was quenched with ice-cold saturated NaHCO3 (20 ml). The 
resulting solution was extracted with ice-cold chloroform (3 x 25 ml). Organic phases were 
combined and dried over MgSO4. The product was purified by column chromatography 
(elution with CH2Cl2/MeOH, 98:2, the column, fractions and column solvents were cooled by 
ice during the column chromatography as 24 was very sensitive to temperature) and dried 
under reduced pressure to give 24 (1.30 g, 87.8%). 
 
Rf = 0.21 (DCM/MeOH; 95:5). 
 
1
H-NMR: (400 MHz, DMSO-d6): δ = 1.34 (s, 3H, isopropylidene-CH3a), 1.56 (s, 3H, 
isopropylidene-CH3b), 1.57 – 1.63 (m, 4H, H2``, H3``), 3.11 (s, 3H, mesyl-CH3), 3.16 – 3.24 
(m, 2H, H4``), 3.25 – 3.36 (m, 2H, H1``), 4.35 – 4.49 (m, 3H, H4’, H5’), 5.08 – 5.12 (m, 1H, 
H3’), 5.45 (dd, 3J = 2.19 Hz, 3J = 6.32 Hz, 1H, H2’), 6.26 (d, 3J = 2.2 Hz, 1H, H1’), 7.95  
(s, br., 1H, 6-NH), 8.25 (s, 1H, H8), 8.32 (s, 1H, H2), 9.42 (t, 
3
J = 5.77 Hz, 1H, amide). 
 
19
F-NMR: (376 MHz, DMSO-d6): δ = -74.41(CF3).  
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5.6.12 N6-(4''-(Trifluoracetamido)butyl)-5'-O-mesyladenosine (25) 
 
 
 
24 (422 mg, 0.76 mmol) was dissolved in 50% formic acid (29.6 ml) to give a colorless 
solution. The reaction mixture was stirred at RT for 3 d. The solvent was removed by 
evaporation and the product was dried by several coevaporations of remaining solvent with 
methanol under reduced pressure to give 25 (356.9 mg, 91.2%). 
 
 Rf = 0.17 (DCM/MeOH; 90:10). 
 
1
H-NMR: (400 MHz, DMSO-d6): δ = 1.48 – 1.61 (m, 4H, H2``, H3``), 3.16 (s, 3H,  
mesyl-CH3), 3.19 – 3.27 (m, 4H, H4``, H1``), 4.13 – 4.17 (m, 1H, H4’), 4.25 – 4.27  
(t, 
3
J = 4.12 Hz, 
3
J = 8.52 Hz, 1H, H3’), 4.40 – 4.49 (m, 2H, H5’), 5.46 (s, br., 1H, OH), 5.62 
(s, br., 1H, OH), 5.94 (d, 
3
J = 5.21 Hz, 1H, H1’), 7.87 (s, br., 1H, 6-NH), 8.22 (s, 1H, H8), 
8.32 (s, 1H, H2), 9.40 (s, br., 1H, amide). 
 
13
C-NMR: (100 MHz, DMSO-d6): δ = 26.28 (C2’’), 26.87 (C3’’), 37.23 (mesyl-C), 39.98 
(C4``, C1``), 70.27 (C5’), 70.61 (C3’), 73.32 (C2’), 81.98 (C4’), 88.05 (C1’), 117.82 (CF3), 
119.89 (C5), 140.47 (C2), 148.93 (C4), 153.06 (C8), 156.34 (carbonyl-C), 156.69 (C6). 
 
19
F-NMR: (376 MHz, DMSO-d6): δ = -74.40 (CF3). 
 
ESI-MS: m/z (%): 551.20 (15) [M + K]
+
,
 
535.40 (55) [M + Na]
+
, 513.53 (30) [M + H]
+
. 
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5.6.13 Aziridine (28) 
 
 
 
KOH (53.2 g, 948 mmol) was dissolved in water (100 ml) at 0 
o
C. 2-Bromoethylamine 
hydrobromide (27) (48.0 g, 234.2 mmol) was added slowly at 0 
o
C and the mixture was stirred 
at RT for 2 h. The resulting product was distilled twice on KOH plates. Aziridine (28)  
(5.00 ml, 41.2%) was obtained as a clear solution (head temperature of the second distillation 
was 56 
o
C). 
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5.6.14 5'-N-Aziridinyl-N6-(4''-aminobutyl)-5'-deoxyadenosine (26) 
 
 
 
25 (100 mg, 195 µmol), EDIA (2 ml, 12.09 mmol) and aziridine (28) (0.7 ml, 13.5 mmol) 
were combined in a round bottom flask and stirred at RT for 3 d. Initially cloudy solution 
turned colorless overnight. Excess of aziridine was removed under reduced pressure. The 
resulting white solid was dissolved in TEAHCO3 buffer (1.5 ml, 10 mM, pH 8) and stirred 
overnight. The product was purified by RP-HPLC (system 1, gradient 5, UV detection:  
280 nm, 300 nm, Rt = 7 min, HPLC2) and fractions containing 26 were stored at -80 
o
C in the 
HPLC elution buffer (60 ml, 0.22 mM, 6.8%). 
 
Rf = 0 (DCM/MeOH; 90:10). 
 
ESI-MS: m/z (%): 364.73 (38) [M + H]
+
. 
 
UV spectrum: λmax = 269 nm (16000). 
 
Rt (system 1, gradient 6, HPLC1) = 12.5 min. 
  
Materials and Methods 
 
98 
 
5.6.15 6RBAz (29) 
 
 
 
19 (1.80 mg, 2.16 µmol) was dissolved in DMA (18 ml), EDIA (18.6 µl, 108 µmol) and 
TBTU (3.50 mg, 10.8 µmol). 26 (18 ml, 0.12 mM, 2.16 µmol) was added dropwise to the 
light-violet solution. The reaction mixture was stirred overnight and product was purified by 
RP-HPLC (system 1, gradient 3, UV detection: 260 nm, 365 nm, Rt = 17 min, HPLC2). 
Volatile components were removed by lyophilization to obtain greenish 29 (386 µg, 15.0%). 
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High resolution reversed-phase LC/ESI-MS (positive ion mode): m/z (%): 988.29  
[M – 2x Et3N + H]
+
 (exact mass deviation, 1.34 ppm). 
 
Rt (system 2, gradient 7) = 1.73 min. 
 
UV spectrum: λmax = 316 nm, λmax local = 382 nm. 
 
Fluorescence spectrum: λex = 384 nm, λem = 434 nm. 
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5.6.16 6TAMRAAz (31) 
 
 
 
26 (22.5 µl, 10.0 nmol) and 30 (TAMRA-NHS) (405 µl in DMSO, 40.0 nmol) were mixed 
together and stirred at RT for 5 h. After monitoring the completion of the reaction, 31 was 
purified by RP-HPLC (system 1, gradient 4, detection: 269 nm, 546 nm, Rt = 18 min, 
HPLC1). 
 
ESI-MS: m/z (%): 776.3 [M + H]
+
.  
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5.6.17 1,4-Diethynylbenzene (14) 
 
 
 
13 (19.3 mg, 71.4 µmol) was dissolved in methanol (5 ml). After addition of K2CO3  
(39.50 mg, 285.6 µmol) the cloudy reaction mixture was stirred overnight. The next day brine 
solution (25 ml) was poured onto the reaction mixture and product was extracted with DCM 
(3 x 25 ml). Organic phases were collected and dried over MgSO4. The solvent was removed 
by using first a rotavapor and then a high vacuum pump to obtain 14 (7.66 mg, 85%) as a 
gray, crystal-like solid.  
 
Rf = 0.64 (cyclohexane/ethylacetate; 10:1). 
 
1
H-NMR: (300 MHz, CDCl3): δ = 3.1 (s, 2H, acetylene), 7.37 (s, 4H, aromatic). 
 
IR (KBr): 3257, 1253, 831 cm
-1
. 
 
MS (EI): m/z (%): 126.1(100) [M]
+
. 
 
CHN-Elemental-Analysis:  Analysis calc: C 95.2; H 4.70 
    Analysis found: C 93.1; H 4.80 
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5.6.18 Di(triethylammonium)-3,3'-(2,5-bis((4-((4-carboxyphenyl)ethynyl) phenyl) 
 ethynyl)-1,4 phenylene)-bis-(oxy)dipropane-1-sulfonate (24) 
 
 
 
A schlenk flask with a stir bar inside was heated in the oven for 15 min. Then, the flask was 
allowed to cool down and flushed with argon for another 15 min. 15 (38.13 mg, 153.8 µmol), 
12 (50 mg, 76.9 µmol) and 14 (19.4 mg, 153.8 µmol) were dissolved in dry THF (4 ml) and 
TEA (0.5 ml). After stirring for 15 min, copper(I) iodide (0.7 mg, 3.8 µmol) and  
dichloro-bis(triphenylphosphine)palladium(II) (5.4 mg, 7.7 µmol) were added to stir at RT 
overnight. For work-up crude product was added to methanol/acetone/diethylether mixture 
(0.5 l, 1:4:5) to precipitate. Solid material was collected by paper filtration. After RP-HPLC 
purification (system 1, gradient 2, detection: 260 nm, 400 nm, Rt = 12.7 min, HPLC1) the 
product was dried under reduced pressure to obtain a light-yellow solid 32 (10 mg, 12.4%). 
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1
H-NMR: (400 MHz, DMSO-d6): δ = 0.94 (t, 18H, triethylammonium-CH3), 2.06 (m, 4H, 
OCH2CH2CH2SO3), 2.47 (q, 12H, triethylammonium-CH2), 2.65 (m, 4H, OCH2CH2CH2SO3), 
4.14 (m, 4H, OCH2CH2CH2SO3), 7.18 (s, 2H, sulfonate aromatic H), 7.59 (m, 4H, 
COOHCCHCHCR), 7.61 (s, 8H, aromatic H), 7.91 (d, 4H, COOHCCHCHCR). 
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5.6.19 PPE-SO3 (33) (n = 20) 
 
 
 
A schlenk flask with a stir bar inside was heated in the oven for 15 min. Then, the flask was 
allowed to cool down and flushed with argon for 15 min. 12 (187 mg, 0.280 mmol) and 14  
(37 mg, 0.29 mmol) were dissolved in a mixture of THF (10 ml), water (10 ml) and DIPA  
(1 ml). After stirring for 15 min, copper(I) iodide (2.80 mg, 14.6 µmol) and 
tetrakis(triphenylphosphine)palladium(0) (33.8 mg, 29.3 µmol) were added to stir at 50 
o
C for 
1 d and then at RT overnight. Crude product was added to methanol/acetone /diethylether 
mixture (1 l, 1:4:5) to precipitate. The liquid was carefully removed with a pipette as much as 
possible. The rest of the suspension was centrifuged, the liquid decantated and the remaining 
Materials and Methods 
 
105 
 
solid was dried under reduced pressure to obtain the product PPE-SO3 (33) (120 mg, 80.5%). 
The degree of polymerization was estimated according to NMR end group analysis. 
 
1
H-NMR: (400 MHz, DMSO-d6): δ = 2.09 (m, 4H, OCH2CH2CH2SO3), 2.70 (t, 
3
J = 6.59 Hz, 
4H, OCH2CH2CH2SO3), 4.17 (s, br., 4H, OCH2CH2CH2SO3), 7.18 (s, 2H, aromatic H), 7.60 
(s, br., 4H, aromatic H).  
 
13
C-NMR: (100 MHz, DMSO-d6): δ = 25.93 (OCH2CH2CH2SO3), 48.37 
(OCH2CH2CH2SO3), 68.65 (OCH2CH2CH2SO3), 117.09 (aromatic-CH), 132.10  
(aromatic-CH).  
 
UV spectrum: λmax = 427 nm, λmax local = 335 nm. 
 
GPC (in water): Mn = 35874 g/mol. 
 
Rt (system 2, gradient 2, HPLC2) = 16.5 min. 
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5.6.20 PPE-SO3 (34) (n = 4) 
 
 
 
A schlenk flask with a stir bar inside was heated in the oven for 15 min. Then, the flask was 
allowed to cool down and flushed with argon for 15 min. 12 (250 mg, 0.385 mmol) and 14  
(49.4 mg, 0.392 mmol) were dissolved in a mixture of THF (10 ml), water (10 ml) and 
pyridine (1 ml). After stirring for 15 min, copper(I) iodide (4.0 mg, 21 µmol) and 
tetrakis(triphenylphosphine)palladium(0) (44 mg, 38 µmol) were added and the reaction 
mixture was stirred at RT for 2 d. The solvents were removed by evaporation; the crude 
product was redissolved in water and dialyzed for one week. The light green product inside 
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the membrane was dried under reduced pressure to obtain PPE-SO3 (34) (6 mg, 2.7%). The 
degree of polymerization was estimated according to NMR end group analysis. 
 
1
H-NMR: (300 MHz, DMSO-d6): δ = 2.09 (s, 4H, OCH2CH2CH2SO3), 2.64 (s, 4H, 
OCH2CH2CH2SO3), 4.11 (s, br., 4H, OCH2CH2CH2SO3), 7.45 (s, br., 6H, aromatic).  
 
UV spectrum: λmax = 370 nm, λmax local = 310 nm. 
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5.6.21 6BAz (35)  
 
 
 
26 (1.6 mg, 4.4 µmol) in elution buffer (7 ml) was combined with biotin-NHS  
(2.3 mg, 6.6 µmol) and stirred at RT for 1 h. The reaction progress was monitored by  
RP-HPLC (system 1, gradient 9, detection: 280 nm, 300 nm, Rt = 13.7 min, HPLC2). The 
product was collected and dried by lyophilization. 6BAz (35) was obtained as a white solid 
(78 µg, 3.0%). 
 
UV spectrum: λmax = 269 nm (16000). 
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5.7 DNA labeling experiments 
5.7.1 Agarose gel electrophoresis 
Agarose (0.35 g) was mixed with 0.5 x TBE buffer (35 ml, 44.5 mM Tris Base, 44.5 mM 
boric acid, 1 mM EDTA, pH 8.0) containing ethidium bromide (0.5 μg/ml) and dissolved by 
heating in a microwave oven. The hot solution (1%) was poured into an electrophoresis 
chamber. After the gel solidified, the samples were supplemented with 6 x loading buffer  
(1:5, v/v, 0.25% bromophenol blue, 30% glycerol) and loaded into the wells. 
 
 
5.7.2 Purification of labeled DNA 
The purification of labeled DNA was performed with a QIAprep Spin Miniprep Kit from 
QIAGEN. The experiment was conducted according to the instructions of the manufacturers. 
Final elution was done in Tris/HCl (50 µl, 10 mM, pH 8.5). 
 
 
5.7.3 Enzymes 
The enzymes were purchased from the following companies. 
Enzyme Company 
BSA Fermentas 
Pfu polymerase  Fermentas 
Pwo polymerase Genaxxon bioscience 
R.EcoRI  MBI Fermentas  
R.HaeII  New England Biolabs  
R.HhaI  New England Biolabs  
R.HindIII  Fermentas 
R.TaqI  MBI Fermentas  
R.XmnI  New England Biolabs  
Streptavidin Gerbu 
Taq polymerase Fermentas 
Tth polymerase Genaxxon bioscience 
Vent polymerase New England Biolabs 
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M.TaqI was kindly provided by Kerstin Glensk in Weinhold group. M.HhaI was kindly 
provided by Dr. S. Klimasauskas (Institute of Biotechnology, Vilnius, Lithuania) and 
M.BseCI by Prof. M. Kokkinidis (University of Crete, Heraklion, Greece). 
 
 
5.7.4 DNAs, DNA ladders, PCR primers 
The following plasmid DNAs were obtained and used as received from the following 
companies: pUC19 and pBR322 from Fermentas Company. 
The green fluorescent protein (GFP) encoding plasmid DNA (pAcGFP1-N2) was received 
from cooperation partner “Fraunhofer-Institut für Lasertechnik” and it was used as provided. 
The sequence is given below: 
TAGTTATTAATAGTAATCAATTACGGGGTCATTAGTTCATAGCCCATATATGGAGT
TCCGCGTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCC
CCGCCCATTGACGTCAATAATGACGTATGTTCCCATAGTAACGCCAATAGGGACT
TTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGGCAGTAC
ATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATG
GCCCGCCTGGCATTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGT
ACATCTACGTATTAGTCATCGCTATTACCATGGTGATGCGGTTTTGGCAGTACATC
AATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTG
ACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCG
TAACAACTCCGCCCCATTGACGCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTC
TATATAAGCAGAGCTGGTTTAGTGAACCGTCAGATCCGCTAGCGCTACCGGACTCA
GATCTCGAGCTCAAGCTTCGAATTCTGCAGTCGACGGTACCGCGGGCCCGGGATCCAC
CGGCCGGTCATGGTGAGCAAGGGCGCCGAGCTGTTCACCGGCATCGTGCCCATCCT
GATCGAGCTGAATGGCGATGTGAATGGCCACAAGTTCAGCGTGAGCGGCGAGGGC
GAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAA
GCTGCCTGTGCCCTGGCCCACCCTGGTGACCACCCTGAGCTACGGCGTGCAGTGCT
TCTCACGCTACCCCGATCACATGAAGCAGCACGACTTCTTCAAGAGCGCCATGCCT
GAGGGCTACATCCAGGAGCGCACCATCTTCTTCGAGGATGACGGCAACTACAAGTC
GCGCGCCGAGGTGAAGTTCGAGGGCGATACCCTGGTGAATCGCATCGAGCTGACC
GGCACCGATTTCAAGGAGGATGGCAACATCCTGGGCAATAAGATGGAGTACAACTA
CAACGCCCACAATGTGTACATCATGACCGACAAGGCCAAGAATGGCATCAAGGTGA
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ACTTCAAGATCCGCCACAACATCGAGGATGGCAGCGTGCAGCTGGCCGACCACTAC
CAGCAGAATACCCCCATCGGCGATGGCCCTGTGCTGCTGCCCGATAACCACTACCT
GTCCACCCAGAGCGCCCTGTCCAAGGACCCCAACGAGAAGCGCGATCACATGATCT
ACTTCGGCTTCGTGACCGCCGCCGCCATCACCCACGGCATGGATGAGCTGTACAAG
TGAGCGGCCGCGACTCTAGATCATAATCAGCCATACCACATTTGTAGAGGTTTTA
CTTGCTTTAAAAAACCTCCCACACCTCCCCCTGAACCTGAAACATAAAATGAATG
CAATTGTTGTTGTTAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAAT
AGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTT
GTCCAAACTCATCAATGTATCTTAAGGCGTAAATTGTAAGCGTTAATATTTTGTTA
AAATTCGCGTTAAATTTTTGTTAAATCAGCTCATTTTTTAACCAATAGGCCGAAAT
CGGCAAAATCCCTTATAAATCAAAAGAATAGACCGAGATAGGGTTGAGTGTTGTT
CCAGTTTGGAACAAGAGTCCACTATTAAAGAACGTGGACTCCAACGTCAAAGGG
CGAAAAACCGTCTATCAGGGCGATGGCCCACTACGTGAACCATCACCCTAATCAA
GTTTTTTGGGGTCGAGGTGCCGTAAAGCACTAAATCGGAACCCTAAAGGGAGCCC
CCGATTTAGAGCTTGACGGGGAAAGCCGGCGAACGTGGCGAGAAAGGAAGGGAA
GAAAGCGAAAGGAGCGGGCGCTAGGGCGCTGGCAAGTGTAGCGGTCACGCTGCG
CGTAACCACCACACCCGCCGCGCTTAATGCGCCGCTACAGGGCGCGTCAGGTGGC
ACTTTTCGGGGAAATGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTC
AAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGA
AAAAGGAAGAGTCCTGAGGCGGAAAGAACCAGCTGTGGAATGTGTGTCAGTTAG
GGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAAGTATGCAAAGCATGCATC
TCAATTAGTCAGCAACCAGGTGTGGAAAGTCCCCAGGCTCCCCAGCAGGCAGAA
GTATGCAAAGCATGCATCTCAATTAGTCAGCAACCATAGTCCCGCCCCTAACTCC
GCCCATCCCGCCCCTAACTCCGCCCAGTTCCGCCCATTCTCCGCCCCATGGCTGAC
TAATTTTTTTTATTTATGCAGAGGCCGAGGCCGCCTCGGCCTCTGAGCTATTCCAG
AAGTAGTGAGGAGGCTTTTTTGGAGGCCTAGGCTTTTGCAAAGATCGATCAAGAG
ACAGGATGAGGATCGTTTCGCATGATTGAACAAGATGGATTGCACGCAGGTTCTC
CGGCCGCTTGGGTGGAGAGGCTATTCGGCTATGACTGGGCACAACAGACAATCG
GCTGCTCTGATGCCGCCGTGTTCCGGCTGTCAGCGCAGGGGCGCCCGGTTCTTTTT
GTCAAGACCGACCTGTCCGGTGCCCTGAATGAACTGCAAGACGAGGCAGCGCGG
CTATCGTGGCTGGCCACGACGGGCGTTCCTTGCGCAGCTGTGCTCGACGTTGTCA
CTGAAGCGGGAAGGGACTGGCTGCTATTGGGCGAAGTGCCGGGGCAGGATCTCC
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TGTCATCTCACCTTGCTCCTGCCGAGAAAGTATCCATCATGGCTGATGCAATGCG
GCGGCTGCATACGCTTGATCCGGCTACCTGCCCATTCGACCACCAAGCGAAACAT
CGCATCGAGCGAGCACGTACTCGGATGGAAGCCGGTCTTGTCGATCAGGATGATC
TGGACGAAGAGCATCAGGGGCTCGCGCCAGCCGAACTGTTCGCCAGGCTCAAGG
CGAGCATGCCCGACGGCGAGGATCTCGTCGTGACCCATGGCGATGCCTGCTTGCC
GAATATCATGGTGGAAAATGGCCGCTTTTCTGGATTCATCGACTGTGGCCGGCTG
GGTGTGGCGGACCGCTATCAGGACATAGCGTTGGCTACCCGTGATATTGCTGAAG
AGCTTGGCGGCGAATGGGCTGACCGCTTCCTCGTGCTTTACGGTATCGCCGCTCCC
GATTCGCAGCGCATCGCCTTCTATCGCCTTCTTGACGAGTTCTTCTGAGCGGGACT
CTGGGGTTCGAAATGACCGACCAAGCGACGCCCAACCTGCCATCACGAGATTTCG
ATTCCACCGCCGCCTTCTATGAAAGGTTGGGCTTCGGAATCGTTTTCCGGGACGCC
GGCTGGATGATCCTCCAGCGCGGGGATCTCATGCTGGAGTTCTTCGCCCACCCTA
GGGGGAGGCTAACTGAAACACGGAAGGAGACAATACCGGAAGGAACCCGCGCT
ATGACGGCAATAAAAAGACAGAATAAAACGCACGGTGTTGGGTCGTTTGTTCATA
AACGCGGGGTTCGGTCCCAGGGCTGGCACTCTGTCGATACCCCACCGAGACCCCA
TTGGGGCCAATACGCCCGCGTTTCTTCCTTTTCCCCACCCCACCCCCCAAGTTCGG
GTGAAGGCCCAGGGCTCGCAGCCAACGTCGGGGCGGCAGGCCCTGCCATAGCCT
CAGGTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTTTAATTTAAAAGG
ATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTT
TTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGAT
CCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGC
GGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCT
TCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCA
CCACTTCAAGAACTCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTAC
CAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACG
ATAGTTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACA
GCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCT
ATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAG
CGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTG
GTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGT
GATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTTTT
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ACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCC
TGATTCTGTGGATAACCGTATTACCGCCATGCAT 
The blue-typed base sequence represents the GFP coding region. The red-highlighted base 
sequences are recognition sequences for the M.HhaI DNA MTase. 
 
484 bp duplex ODN was obtained from cooperation partner Prof. Friedhoff  
(Justus-Liebig Universität Giessen) and used as received. The 484 bp duplex ODN contains 
only one GATC sequence (highlighted yellow) and it has no mismatch. 
The sequence is given below: 
TCATCCTCGG CACCGTCACC CTGGATGCTG TAGGCATAGG CTTGGTTATG 
CCGGTACTGC CGGGCCTCTT GCGGGATATC CGGATATAGT TCCTCCTTTC 
AGCAAAAAAC CCCTCAAGAC CCGTTTAGAG GCCCCAAGGG GTTATGCTAG 
TTATTGCTCA GCGGTGGCAG CAGCCAACTC AGCTTCCTTT CGGGCTTTGT 
TAGCAGCCGG ATCCTCGAGC ATATGGCTGC CGCGCGGCAC CAGGCCGCTG 
CTGTGATGAT GATGATGATG GCTGCTGCCC ATGGTATATC TCCTTCTTAA 
AGTGGATCCA AATTATTTCT AGAGGGGAAT TGTTATCCGC TCAGGTTCCC 
CCTATAGTGA GTCGGTTCCA TTTGGTTCCC TCGAAAGCTT CATCCTCTAC 
GCCGGACGCA TCGTGGCCGG CATCACCGGC GCCACAGGTG CGGTTGCTGG 
CGCCTATATC GCCGACATCA CCGATGGGGA AGAT 
 
Following abbreviations were used to explain the 484 bp duplex ODNs: 
HO: Homoduplex with an extra GATC site (highlighted red),  
HE: Heteroduplex with an extra GATC site containing a G/T mismatch (highlighted green A 
is G) on R.HindIII restriction site. 
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The following DNA ladders were used for the gel electrophoreses; 
Company Product number Abbreviation 
Fermentas  SM0403 Ladder 1 
Fermentas Fermentas Ladder 2 
NEB NEB Ladder 3 
 
 
The following PCR primers were used for the PCR amplifications; 
Company Batch number 
Eurogentec 693165 
Eurogentec 693166 
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5.7.5 Labeling of pAcGFP1-N2 DNA with 6TexAz (47) and M.HhaI 
pAcGFP1-N2 plasmid DNA (10 µg, 3.22 pmol; 27 recognition sequences for M.HhaI) was 
incubated with 6TexAz (47) (25 µM) and M.HhaI (139 pmol). The reaction was performed in 
buffer (400 μl; 10 mM Tris/HCl, pH 7.4), 50 mM NaCl, EDTA (0.05 mM) and 2 mM  
ß-mercaptoethanol at 37 °C for 3 h. The reaction was stopped by heating at 75 
o
C for 15 min. 
Finally the labeled DNA was purified with the QIAprep Spin Miniprep Kit. 6TexAz (47) was 
provided by former Ph.D. student Dr. Michael Hueben. 
 
 
5.7.6 Restriction of pAcGFP1-N2 DNA labeled with 6TexAz (47) and M.HhaI 
Labeled plasmid DNA (5 µl, 25 ng), 10 x NEB4 (1.6 µl, New England Biolabs), 10 x BSA  
(1.6 µl) and R.HaeII (1 U per 25 ng) were mixed with water to give a total volume of 16 µl. 
Restriction probe was incubated at 37 
o
C for 1 h. 
 
 
5.7.7 PCR amplification of pAcGFP1-N2 DNA labeled with 6TexAz (47) and M.HhaI 
Labeled plasmid DNA in s. 5.7.5 (1 µl, 5 ng), primer 1 and primer 2 (1 µl, 0.1 nmol), 
commercially delivered corresponding polymerase 10 x buffer (10 µl) and polymerase 
enzymes (Pfu, Taq, Tth, Vent each 1 µl; 2.5 U, 5 U, 5 U, 2 U, respectively) were diluted with 
water to a 100 µl total volume.  
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The PCR conditions for program 1: 
 
Cycle 
number 
Temperature 
(
o
C) 
Duration Cycle 
number 
Temperature 
(
o
C) 
Duration 
1 95 2 min 9 94 30 sec 
2 94 30 sec 10 58 45 sec 
3 58 45 sec 11 72 45 sec 
4 72 45 sec 12 Repeat cycle 9, 3times 
5 Repeat cycle 2, 3times 13 72 2 min 
6 72 2 min 14 4  
7 4  15 Repeat cycle9, 3times 
8 94 2 min 16 4 end 
 
Labeled DNA (4 µl, 127 ng), primer 1 and primer 2 (0.5 µl, 0.05 nmol), commercially 
supplied Pwo polymerase 10 x buffer (5 µl) and polymerase enzyme (Pwo 1 µl, 2.5 U) were 
diluted with water to 50 µl total volume.  
The PCR conditions for program 2: 
 
Cycle 
number 
Temperature 
(
o
C) 
Duration Cycle 
number 
Temperature 
(
o
C) 
Duration 
1 95 2 min 9 95 45 sec 
2 95 45 sec 10 58 45 sec 
3 58 45 sec 11 72 2 min 
4 72 2 min 12 Repeat cycle 9, 4 times 
5 Repeat cycle 2, 14 times 13 72 5 min 
6 72 5 min 14 4  
7 4  15 Repeat cycle 9, 2 times 
8 95 2 min 16 4 end 
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5.7.8 Linearization of pAcGFP1-N2 DNA with R.HindIII enzyme 
The linearization of pAcGFP1-N2 DNA (10 ng) was performed with R.HindIII (1 µl, 10 U), 
commercially supplied buffer (10 x NEB2 buffer, 1 µl) and water in a final volume of  
10 µl. Incubation took place at 37 
o
C for 1 h. 
 
 
5.7.9  Linearization of pUC19 DNA with R.XmnI  
The linearization of plasmid pUC19 DNA (10 µg) was performed with R.XmnI (100 U), 
commercially supplied buffer (10 x NEB2 buffer, 4 µl), BSA (4 µg) and water in a final 
volume of 40 µl. Incubation took place at 37 
o
C for 1 h. The resulting DNA was purified by 
QIAprep Spin Miniprep Kit from QIAGEN. 
 
 
5.7.10 Restriction of R.XmnI linearized DNA with R.HindIII 
R.XmnI linearized pUC19 DNA (125 ng) was cut with R.HindIII (10 U) in commercially 
supplied buffer (10 x NEB2 buffer, 1 µl) and water in a final volume of 10 µl. The reaction 
mixture was analyzed by gel electrophoresis. 
 
 
5.7.11 Labeling of linearized pUC19 DNA with 8BAz (48) and M.TaqI 
R.XmnI-linearized pUC19 DNA (25 ng/µL, 14.1 nM) was biotinylated with aziridine cofactor 
8BAz (48) (80 µM) and M.TaqI (226 nM) in Tris/OAc (20 mM, pH 6.0), KOAc (50 mM), 
Mg(OAc)2 (10 mM) and Triton X-100 (0.01%) at 65 °C for 5 h. The labeled plasmid was 
purified using the QIAquick PCR Purification Kit according to the instructions of the 
manufacturer. After elution with buffer (50 µl, 10 mM Tris-HCl, pH 8.5) the solution was 
incubated at 80 °C for 30 min. 8BAz (48) was provided by former Ph.D. student Dr. Falk 
Schmidt. 
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5.7.12 R.TaqI treatment of R.XmnI linearized pUC19 DNA labeled with 8BAz (48) and 
 M.TaqI 
Labeled R.XmnI-linearized pUC19 DNA (100 ng, s. 5.7.11), Tris-HCl (10 mM, pH 8.0), 
MgCl2 (5 mM), NaCl (100 mM), BSA (0.1 mg/ml) and R.TaqI (1 U) were incubated at 65 
o
C 
for 1 h. The reaction mixture was analyzed by gel electrophoresis. 
 
 
5.7.13 Labeling of plasmid pBR322 DNA with 6BAz (35) and M.BseCI 
pBR322 DNA (2.0 µg, 0.71 pmol; 1 recognition sequence for M.BseCI) was incubated with 
M.BseCI (7 pmol), 6BAz (35) (80 µM) in 250 μl Tris/HCl (10 mM, pH 7.4), Triton X  
(0.02 %), EDTA (10 mM) and ß-mercaptoethanol (5 mM) at 55 °C for 3 h. The reaction was 
stopped by heating at 75 
o
C for 15 min. Then streptavidin (1.11 µg per 1 µg DNA) was added 
and incubated for 1 h at RT.  
 
 
5.7.14 R.TaqI restriction of pBR322 DNA labeled with 6BAz (35) and M.BseCI 
Labeled pBR322 DNA (100 ng) from s. 5.7.13, Tris-HCl (10 mM, pH 8.0), MgCl2 (5 mM), 
NaCl (100 mM), BSA (0.1 mg/ml) and R.TaqI (1 U) were incubated at 65 
o
C for 1 h. The 
reaction mixture was analyzed by gel electrophoresis. 
 
 
5.7.15 Labeling of duplex ODN with 6BAz (35) and M.TaqI 
Duplex ODN (79 nM) was labeled with aziridine cofactor 6BAz (35) (80 µM) and M.TaqI 
(632 nM, 2 recognition sites) in Tris/OAc (20 mM, pH 6.0), KOAc (50 mM), Mg(OAc)2  
(10 mM) and Triton X-100 (0.01%) at 65 °C for 5 h. Labeled duplex ODN was purified using 
the QIAquick PCR Purification Kit according to the instructions of the manufacturer. DNA 
was obtained by elution with buffer (50 µl, 10 mM Tris-HCl, pH 8.5). 
Restriction assays were performed with R.TaqI enzyme. Labeled duplex ODN (100 ng),  
Tris-HCl (10 mM, pH 8.0 at 37 °C), MgCl2 (5 mM), NaCl (100 mM), BSA (0.1 mg/ml) and 
R.TaqI (1 U) were incubated at 65 
o
C for 1 h. The reaction mixture was analyzed by agarose 
gel electrophoresis. 
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5.7.16 Labeling of duplex ODN with 6BAz (35) and M.HhaI 
Duplex ODN (79 nM) was labeled with aziridine cofactor 6BAz (35) (80 µM) and M.HhaI 
(632 nM, 2 recognition sites) in Tris/OAc (20 mM, pH 6.0), KOAc (50 mM), Mg(OAc)2  
(10 mM) and Triton X-100 (0.01%) at 65 °C for 5 h. Labeled duplex ODN was purified using 
the QIAquick PCR Purification Kit according to the instructions of the manufacturer. DNA 
was obtained by elution with buffer (50 µl, 10 mM Tris-HCl, pH 8.5). 
Restriction assays were performed with R. HhaI enzyme. Labeled duplex ODN (100 ng), 
Tris-HCl (10 mM, pH 8.0), MgCl2 (5 mM), NaCl (100 mM), BSA (0.1 mg/ml) and R. HhaI  
(1 U) were incubated at 65 
o
C for 1 h. The reaction mixture was analyzed by agarose gel 
electrophoresis. 
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